pert_iname,clinical_phase,moa,target,disease_area,indication,matching_in_cellminercdb,kw_matching,
usniacin-(+),Preclinical,MAP kinase activator,PTPN1,,,FALSE,(+)-usnic acid,
3-amino-benzamide,Phase 2,PARP inhibitor,PARP1,,,FALSE,3-aminobenzamide,
fdcyd,Phase 2,DNA methyltransferase inhibitor,,,,FALSE,5-fluoro-2'-deoxycytidine,
abiraterone-acetate,Launched,androgen biosynthesis inhibitor,CYP17A1,oncology,prostate cancer,SYN,abiraterone,
adefovir-dipivoxil,Launched,DNA polymerase inhibitor,,infectious disease,hepatitis B,FALSE,adefovir dipivoxil,
ADL5859,Phase 2,opioid receptor agonist,OPRD1,,,FALSE,adl-5859,
tyrphostin-AG-1478,Preclinical,EGFR inhibitor,EGFR|MAPK14,,,FALSE,ag-1478,
CD-437,Preclinical,retinoid receptor agonist,RARG,,,FALSE,ahpn,
maytansinol-isobutyrate,Preclinical,,,,,FALSE,ansamitocin p3,
STA-5326,Phase 2,interleukin synthesis inhibitor,IL12A,,,FALSE,apilimod,
dihydroartemisinin,Launched,antimalarial agent,,infectious disease,malaria,FALSE,artenimol,
AT7867,Preclinical,AKT inhibitor,AKT2|GSK3B|PKIA|PRKACA,,,FALSE,at-7867,
aurora-a-inhibitor-i,Preclinical,Aurora kinase inhibitor,AURKA,,,FALSE,aurora a inhibitor i,
AZ3146,Preclinical,monopolar spindle 1 kinase inhibitor,,,,FALSE,az-3146,
AZ960,Preclinical,JAK inhibitor,JAK2,,,FALSE,az-960,
AZD3463,Preclinical,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,ALK|IGF1R,,,FALSE,azd-3463,
AZD5438,Phase 1,CDK inhibitor,KCNH2,,,FALSE,azd-5438,
AZD6482,Phase 1,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,,FALSE,azd-6482,
azomycin-(2-nitroimidazole),Preclinical,protein synthesis inhibitor,,,,FALSE,azomycin,
bardoxolone-methyl,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,,,SYN,bardoxolone methyl,
betamethasone-dipropionate,Launched,anti-inflammatory agent,NR3C1,dermatology,corticosteroid-responsive dermatoses,FALSE,betamethasone dipropionate,
dexamethasone-acetate,Launched,glucocorticoid receptor agonist,,endocrinology|rheumatology|allergy|gastroenterology|hematology|neurology/psychiatry|dermatology,hypercalcemia|rheumatoid arthritis|psoriatic arthritis|osteoarthritis|allergic rhinitis|ulcerative colitis|anemia|multiple sclerosis|enteritis|lupus|dermatitis herpetiformis (DH)|nephrotic syndrome|psoriasis,FALSE,betamethasone valerate,
betulinic-acid,Phase 1/Phase 2,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,,,FALSE,betulinic acid,
PI3K-IN-2,Phase 2,PI3K inhibitor,,,,FALSE,bimiralisib,
4-methylgenistein,Preclinical,protein tyrosine kinase inhibitor,CYP19A1|ESRRA|ESRRB|ESRRG|FASN,,,FALSE,biochanin a,
blebbistatin-(-),Preclinical,ATPase inhibitor,,,,FALSE,(-)-blebbistatin,
brefeldin-A,Preclinical,protein synthesis inhibitor,ARF1|CYTH2,,,FALSE,brefeldin a,
buthionine-sulfoximine,Phase 1,glutathione transferase inhibitor,GCLM,,,FALSE,buthionine sulfoximine,
ZK-811752,Phase 2,CC chemokine receptor antagonist,CCR1,,,FALSE,bx-471,
caffeic-acid,Preclinical,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,ALOX5|MIF,,,FALSE,caffeic acid,
cholecalciferol,Launched,,VDR,endocrinology,vitamin D deficiency,FALSE,,
INC-280,Phase 3,c-Met inhibitor,MET,,,FALSE,capmatinib,
CCT129202,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,,FALSE,cct-129202,
CCT137690,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,,FALSE,cct-137690,
cefditoren-pivoxil,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|pulmonary|otolaryngology,pneumonia|bronchitis|skin infections|tonsillitis|pharyngitis,FALSE,cefditoren pivoxil,
levocetirizine,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria,FALSE,cetirizine hydrochloride,
CH5132799,Phase 1,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,,,FALSE,ch-5132799,
chloramphenicol-palmitate,Launched,protein synthesis inhibitor,,infectious disease|endocrinology,meningitis|fever|cholera,FALSE,chloramphenicol palmitate,
clindamycin-phosphate,Launched,protein synthesis inhibitor,,obstetrics/gynecology,bacterial vaginosis,FALSE,clindamycin hydrochloride,clindamycin palmitate
clobetasol-propionate,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses,FALSE,clobetasol propionate,
crizotinib-(S),Preclinical,MTH1 inhibitor,NUDT1,,,SYN,crizotinib,
CHIR-98014,Preclinical,glycogen synthase kinase inhibitor,GSK3A|GSK3B,,,FALSE,ct-98014,
cyclosporin-A,Launched,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,rheumatology|dermatology,rheumatoid arthritis|psoriasis,FALSE,cyclosporine,
cyclovirobuxin-D,Preclinical,calcium channel modulator,,,,FALSE,cyclovirobuxin d,
cyproterone-acetate,Launched,androgen receptor antagonist,ADORA1|AR,oncology,prostate cancer,FALSE,cyproterone acetate,
NVP-BEZ235,Phase 3,mTOR inhibitor|PI3K inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,,,FALSE,dactolisib,
digitoxin,Launched,ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,cardiology,congestive heart failure|cardiac arrythmia,SYN,digoxin,
dolastatin-10,Phase 2,tubulin polymerization inhibitor,TUBB,,,FALSE,dolastatin 10,
epothilone-A,Preclinical,microtubule stabilizing agent,,,,FALSE,epothilone a,
epothilone-D,Phase 2,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,,,FALSE,epothilone d,
estramustine-phosphate,Launched,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,oncology,prostate cancer,SYN,estramustine phosphate,
ethinyl-estradiol,Launched,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,endocrinology,contraceptive,FALSE,ethinyl estradiol,
etoposide-phosphate,Launched,topoisomerase inhibitor,TOP2A,oncology,testicular carcinoma|small cell lung cancer,SYN,etoposide,
exatecan-mesylate,Phase 3,topoisomerase inhibitor,TOP1,,,FALSE,exatecan,
fludarabine-phosphate,Launched,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,hematologic malignancy,chronic lymphocytic leukemia (CLL),SYN,fludarabine,
fluocinolone-acetonide,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,dermatology,seborrheic dermatitis,FALSE,fluocinolone acetonide,
fluticasone-propionate,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,dermatology,corticosteroid-responsive dermatoses,FALSE,fluticasone propionate,
crystal-violet,Launched,other antibiotic,,,,FALSE,gentian violet,
ginkgolide-A,Preclinical,GABA receptor antagonist,GLRA1|GLRB,,,FALSE,ginkgolide a,
GSK1292263,Phase 2,glucose dependent insulinotropic receptor agonist,GRPR,,,FALSE,gsk-1292263,
GSK256066,Phase 2,phosphodiesterase inhibitor,PDE4A,,,FALSE,gsk-256066,
GSK2656157,Preclinical,PERK inhibitor,,,,FALSE,gsk-2656157,
GW-3965,Preclinical,LXR agonist,NR1H2|NR1H3,,,FALSE,gsk-3965,
GW-441756,Preclinical,growth factor receptor inhibitor,NTRK1,,,FALSE,gw441756x,
GW-842166,Phase 2,cannabinoid receptor agonist,CNR2,,,FALSE,gw842166,
GZD824,Preclinical,Bcr-Abl kinase inhibitor,ABL1|BCR,,,FALSE,gzd-824,
butylscopolamine-bromide,Launched,cholinergic receptor antagonist,,gastroenterology,abdominal pain,FALSE,hyoscine n-butyl bromide,
ingenol-mebutate,Launched,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,dermatology,actinic keratosis (AK),FALSE,ingenol mebutate,
JQ1-(+),Preclinical,bromodomain inhibitor,BRD4|BRDT,,,FALSE,jq1,
KD025,Phase 2,rho associated kinase inhibitor,ROCK2,,,FALSE,kd-025,
KY02111,Preclinical,WNT pathway inhibitor,DKK1,,,FALSE,ky-02111,
lappaconite,Phase 2,sodium channel blocker,,,,FALSE,lappaconitine,
LY2334737,Phase 1,antitumor agent|ribonucleotide reductase inhibitor,,,,FALSE,ly-2334737,
mitomycin-C,Launched,DNA alkylating agent|DNA synthesis inhibitor,,oncology,pancreatic cancer|gastric adenocarcinoma,FALSE,mitomycin,
ixazomib-citrate,Launched,proteasome inhibitor,,hematologic malignancy,multiple myeloma,FALSE,mln-9708,
mycophenolate-mofetil,Launched,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,transplant,organ rejection,FALSE,mycophenolate mofetil,
mycophenolic-acid,Launched,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,transplant,organ rejection,FALSE,mycophenolic acid,
RG108,Preclinical,DNA methyltransferase inhibitor,DNMT1|DNMT3B,,,FALSE,nsc-401077,
oleanolic-acid,Preclinical,G protein-coupled receptor agonist,GPBAR1,,,FALSE,oleanolic acid,
oligomycin-A,Preclinical,ATP synthase inhibitor|ATPase inhibitor,ATP5A1,,,FALSE,oligomycin a,
oseltamivir-phosphate,Launched,neuraminidase inhibitor,CES1|NEU1|NEU2,infectious disease,influenza A virus infection,FALSE,oseltamivir phosphate,
"CP-945,598",Phase 3,cannabinoid receptor antagonist,CNR1,,,FALSE,otenabant,
oxonic-acid,Preclinical,uricase inhibitor,,,,FALSE,oteracil potassium,
OTS167,Phase 1/Phase 2,maternal embryonic leucine zipper kinase inhibitor,MELK,,,FALSE,ots-167,
aminophylline,Launched,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,pulmonary,asthma|bronchitis|emphysema,FALSE,oxtriphylline,
rheochrysidin,Preclinical,protein tyrosine kinase inhibitor,PTPN1,,,FALSE,parietin,
parthenolide-(-),Preclinical,NFkB pathway inhibitor,HDAC1,,,SYN,parthenolide,
epothilone-B,Phase 3,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,,,FALSE,patupilone,
penicillamine-(D),Launched,chelating agent,,metabolism|rheumatology|nephrology,Wilson's disease|rheumatoid arthritis|cystinuria,FALSE,penicillamine,
prednisolone-acetate,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis,FALSE,prednisolone acetate,
PRT062607,Phase 2,SYK inhibitor,FGR|MAP3K9|SYK,,,FALSE,prt-062607,
R406,Phase 1,SYK inhibitor,RET|SYK,,,FALSE,r-406,
P276-00,Phase 2,CDK inhibitor,CDK1|CDK4|CDK9,,,FALSE,riviciclib,
bisindolylmaleimide-IX,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,,,FALSE,ro-31-8425,
FG-4592,Phase 3,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN1|EGLN2|EGLN3,,,FALSE,roxadustat,
MLN0128,Phase 2,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,,,FALSE,sapanisertib,
SAR131675,Preclinical,VEGFR inhibitor,FLT4,,,FALSE,sar-131675,
SID-7969543,Preclinical,steroidogenic factor antagonist,NR5A1,,,FALSE,sid 7969543,
PSI-7976,Preclinical,HCV inhibitor,,,,FALSE,sofosbuvir,
stemregenin-1,Preclinical,aryl hydrocarbon receptor antagonist,AHR,,,FALSE,stemregenin 1,
tanshinone-I,Phase 2,AP inhibitor,IFNG,,,FALSE,tanshinone i,
telotristat-ethyl,Launched,tryptophan hydroxylase inhibitor,TPH1,gastroenterology,diarrhea,FALSE,telotristat etiprate,
torin-1,Preclinical,mTOR inhibitor,MTOR,,,FALSE,torin1,
torasemide,Launched,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,cardiology,edema|congestive heart failure|hypertension,FALSE,torsemide,
triamcinolone-acetonide,Launched,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6,dermatology,corticosteroid-responsive dermatoses,SYN,triamcinolone acetonide,
trichostatin-a,Phase 1,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,,FALSE,trichostatin a,
UNC0631,Preclinical,histone lysine methyltransferase inhibitor,EHMT2,,,FALSE,unc-0631,
SC-12267,Phase 2,dihydroorotate dehydrogenase inhibitor,IL17A,,,FALSE,vidofludimus,
voreloxin,Phase 3,topoisomerase inhibitor,TOP2A,,,FALSE,vosaroxin,
WP1066,Phase 1,STAT inhibitor,STAT3,,,FALSE,wp 1066,
WZ8040,Preclinical,EGFR inhibitor,EGFR,,,FALSE,wz-8040,
XL388,Preclinical,mTOR inhibitor,MTOR,,,FALSE,xl-388,
ribitol,Preclinical,,,,,FALSE,xylitol,
12-O-tetradecanoylphorbol-13-acetate,Phase 2,PKC activator,KCNT2|TRPV4,,,FALSE,,
1-azakenpaullone,Preclinical,glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,,,FALSE,,
1-naphthyl-PP1,Preclinical,SRC inhibitor,SRC,,,FALSE,,
1-phenylbiguanide,Preclinical,serotonin receptor agonist,HTR3A|HTR3B,,,FALSE,,
"2,3-DCPE",Preclinical,BCL-XL downregulator,BCL2L1,,,FALSE,,
2'-MeCCPA,Preclinical,adenosine receptor agonist,ADORA1,,,FALSE,,
"3,4-methylenedioxy-beta-nitrostyrene",Preclinical,SRC inhibitor|SYK inhibitor,SRC|SYK,,,FALSE,,
3-deazaneplanocin-A,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,,FALSE,,
3'-fluorobenzylspiperone,Preclinical,dopamine receptor ligand,DRD2,,,FALSE,,
4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,Preclinical,serotonin receptor antagonist,HTR2A,,,FALSE,,
4-chlorophenylguanidine,Preclinical,urokinase inhibitor,PLAUR,,,FALSE,,
4E1RCat,Preclinical,protein synthesis inhibitor,EIF4E|EIF4G1,,,FALSE,,
4-hydroxy-phenazone,Preclinical,,,,,FALSE,,
4-iodo-6-phenylpyrimidine,Preclinical,macrophage migration inhibiting factor inhibitor,MIF,,,FALSE,,
4-methylhistamine,Preclinical,histamine receptor agonist,HRH4,,,FALSE,,
4-pyrimidinecarbonitrile,Preclinical,,,,,FALSE,,
5-hydroxymethyl-tolterodine,Phase 1,acetylcholine receptor antagonist,CHRM3,,,FALSE,,
7-aminocephalosporanic-acid,Preclinical,beta lactamase inhibitor,,,,FALSE,,
7-nitroindazole,Preclinical,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,,,FALSE,,
8-bromo-cGMP,Preclinical,PKA activator,PRKG1,,,FALSE,,
8-hydroxy-PIPAT,Preclinical,dopamine receptor ligand,DRD2|DRD3,,,FALSE,,
9-aminoacridine,Preclinical,,,,,FALSE,,
A61603,Preclinical,adrenergic receptor agonist,ADRA1A,,,FALSE,,
AC-264613,Preclinical,PAR agonist,F2RL1,,,FALSE,,
ACDPP,Preclinical,glutamate receptor antagonist,GRM5,,,FALSE,,
acesulfame-potassium,Phase 3,,,,,FALSE,,
acetazolamide,Launched,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,ophthalmology,glaucoma,FALSE,,
acetophenazine,Launched,dopamine receptor antagonist,DRD1|DRD2,neurology/psychiatry,psychosis,FALSE,,
acetylsalicylsalicylic-acid,Preclinical,cyclooxygenase inhibitor,,,,FALSE,,
acivicin,Phase 2,gamma glutamyltransferase inhibitor,CTPS1,,,FALSE,,
adaprev,Phase 3,TGF beta receptor inhibitor,AKR1B1|GPI|HK1|M6PR|PYGM,,,FALSE,,
adarotene,Phase 1,retinoid receptor agonist,RARB|RARG,,,FALSE,,
AEG3482,Preclinical,HSP inducer,,,,FALSE,,
afobazole,Launched,anxiolytic,,neurology/psychiatry,anxiety,FALSE,,
ajmaline,Launched,sodium channel blocker,,cardiology,Wolff-Parkinson-White Syndrome (WPW),FALSE,,
alexidine,Preclinical,phosphatidylglycerophosphatase inhibitor,PTPMT1,,,FALSE,,
alfacalcidol,Launched,vitamin D receptor agonist,CYP27B1|VDR,endocrinology,vitamin D deficiency,FALSE,,
almorexant,Phase 3,orexin receptor antagonist,HCRTR1|HCRTR2,,,FALSE,,
alogliptin,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,FALSE,,
AM095,Preclinical,lysophosphatidic acid receptor antagonist,,,,FALSE,,
AM-251,Preclinical,cannabinoid receptor antagonist,CNR1|GPR18|GPR55,,,FALSE,,
AM-404,Preclinical,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,CNR1|CNR2|FAAH|TRPV1,,,FALSE,,
AM-580,Preclinical,retinoid receptor agonist,RARA,,,FALSE,,
ambazone,Phase 1,DNA damage inducer,,,,FALSE,,
amfenac,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief,FALSE,,
aminopurvalanol-a,Preclinical,CDK inhibitor|tyrosine kinase inhibitor,CDK1|CDK2|CDK5,,,FALSE,,
ammonium-lactate,Launched,,HCAR1,dermatology,xerosis cutis|ichthyosis vulgaris,FALSE,,
amprolium,Launched,thiamine uptake blocker,,infectious disease,coccidiosis,FALSE,,
anguidine,Phase 2,protein synthesis inhibitor,SLC5A1,,,FALSE,,
anisomycin,Preclinical,DNA synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,,,FALSE,,
AP1903,Phase 1/Phase 2,,MTOR,,,FALSE,,
aphidicolin,Phase 1,RNA synthesis inhibitor,,,,FALSE,,
arctigenin,Preclinical,MEK inhibitor,CHUK|MAP2K1,,,FALSE,,
arcyriaflavin-a,Preclinical,CDK inhibitor,CCND1|CDK4,,,FALSE,,
astemizole,Withdrawn,histamine receptor antagonist,HRH1|KCNH1|KCNH2,,,FALSE,,
asymmetrical-dimethylarginine,Phase 1,nitric oxide synthase inhibitor,NOS2|NOS3,,,FALSE,,
atenolol-(-),Launched,adrenergic receptor antagonist,,cardiology,hypertension,FALSE,,
atenolol-(+/-),Launched,adrenergic receptor antagonist,ADRB1|ADRB2|LTF|PLA2G2E,cardiology,hypertension|angina pectoris,FALSE,,
atipamezole,Launched,adrenergic receptor antagonist,,neurology/psychiatry,reverse sedative,FALSE,,
avanafil,Launched,phosphodiesterase inhibitor,PDE5A,urology,erectile dysfunction,FALSE,,
AZ20,Preclinical,ATR kinase inhibitor,ATR|MTOR,,,FALSE,,
azilsartan,Launched,angiotensin receptor antagonist,AGTR1|AGTR2,cardiology,hypertension,FALSE,,
azodicarbonamide,Phase 2,DNA synthesis inhibitor,,,,FALSE,,
balapiravir,Phase 2,RNA polymerase inhibitor,,,,FALSE,,
BAN-ORL-24,Preclinical,nociceptin/orphanin FQ receptor antagonist,OPRL1,,,FALSE,,
BAY-11-7082,Preclinical,NFkB pathway inhibitor,RELA,,,FALSE,,
BAY-11-7085,Preclinical,NFkB pathway inhibitor,NFKBIA,,,FALSE,,
BAY-87-2243,Phase 1,hypoxia inducible factor inhibitor,HIF1A,,,FALSE,,
BAY-K-8644-(s)-(-),Preclinical,L-type calcium channel activator,CACNA1C,,,FALSE,,
beclomethasone-dipropionate,Launched,glucocorticoid receptor agonist,GPR97|NR3C1,allergy,allergic rhinitis,FALSE,,
bekanamycin,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,FALSE,,
bendroflumethiazide,Launched,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,cardiology,hypertension,FALSE,,
benfotiamine,Launched,antioxidant,AGER,rheumatology,lumbago,FALSE,,
benzethonium,Launched,sodium channel blocker,SCN10A,infectious disease,first-aid antiseptic,FALSE,,
benzocaine,Launched,sodium channel blocker,SCN10A,infectious disease,first-aid antiseptic,FALSE,,
benzydamine,Launched,prostanoid receptor antagonist,,dental|otolaryngology,mouth inflammation|throat inflammation,FALSE,,
benzyldimethylhexadecylammonium,Preclinical,cationic surfactant,,,,FALSE,,
bephenium-hydroxynaphthoate,Launched,anthelmintic agent,,infectious disease,ascariasis,FALSE,,
beta-naphthol,Preclinical,,,,,FALSE,,
BIBU-1361,Preclinical,EGFR inhibitor,EGFR,,,FALSE,,
BIBX-1382,Phase 1,EGFR inhibitor,EGFR|ERBB2,,,FALSE,,
bifemelane,Launched,acetylcholine release enhancer,MAOA|MAOB,ophthalmology|neurology/psychiatry,glaucoma|senile dementia,FALSE,,
bis(maltolato)oxovanadium(IV),Phase 2,tyrosine phosphatase inhibitor,PTPN1,,,FALSE,,
bitopertin,Phase 3,glycine transporter inhibitor,SLC6A5|SLC6A9,,,FALSE,,
BMS-626529,Phase 3,HIV attachment inhibitor,,,,FALSE,,
BNC105,Phase 2,tubulin polymerization inhibitor,,,,FALSE,,
BNTX,Preclinical,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,,,FALSE,,
bosentan,Launched,endothelin receptor antagonist,EDNRA|EDNRB,pulmonary,pulmonary arterial hypertension (PAH),FALSE,,
brilliant-green,Launched,,,infectious disease,antiseptic,FALSE,,
bromosporine,Preclinical,bromodomain inhibitor,,,,FALSE,,
broxaldine,Preclinical,,,,,FALSE,,
broxyquinoline,Phase 1,antiprotozoal agent,,,,FALSE,,
BTS-54505,Withdrawn,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,,,FALSE,,
bucladesine,Launched,adenosine receptor agonist|cAMP stimulant,PRKACA,dermatology,skin ulcer,FALSE,,
buphenine,Launched,adrenergic receptor agonist,ADRB2,rheumatology,Raynaud's disease,FALSE,,
butamben,Withdrawn,sodium channel blocker,,,,FALSE,,
BVT-948,Preclinical,tyrosine phosphatase inhibitor,PTPN1|PTPN11|PTPN2,,,FALSE,,
BW-180C,Phase 2,opioid receptor agonist,OPRD1|OPRM1,,,FALSE,,
caffeic-acid-phenethyl-ester,Preclinical,HIV integrase inhibitor,RELA,,,FALSE,,
calcium-gluceptate,Launched,,,,,FALSE,,
camylofine-chlorhydrate,Launched,,,gastroenterology,abdominal pain,FALSE,,
candesartan,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension|congestive heart failure,FALSE,,
canrenone,Withdrawn,mineralocorticoid receptor antagonist,NR3C2,,,FALSE,,
captamine,Preclinical,,,,,FALSE,,
carbachol,Launched,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,ophthalmology,intraocular pressure,FALSE,,
carboxypyridine-disulfide,Phase 2,,,,,FALSE,,
cariporide,Phase 3,sodium/hydrogen exchanger inhibitor,SLC9A1,,,FALSE,,
CB-10-277,Phase 1,DNA synthesis inhibitor,,,,FALSE,,
CCG-50014,Preclinical,G protein signaling inhibitor,RGS4|RGS8,,,FALSE,,
CCMI,Preclinical,acetylcholine receptor allosteric modulator,CHRNA7,,,FALSE,,
cefpiramide,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,FALSE,,
cetrimonium,Launched,,,dermatology,cosmetic,FALSE,,
cetylpyridinium,Launched,,,dental,gingivitis|mouth inflammation,FALSE,,
CGP-37849,Phase 1,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,,,FALSE,,
CGP-52411,Preclinical,EGFR inhibitor,EGFR,,,FALSE,,
CGP-54626,Preclinical,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,,,FALSE,,
CGS-15943,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,,FALSE,,
CGS-20625,Phase 1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,,,FALSE,,
chicago-sky-blue-6b,Preclinical,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MIF,,,FALSE,,
chlorindanol,Preclinical,,,,,FALSE,,
chlormidazole,Launched,fungal lanosterol demethylase inhibitor,,infectious disease,fungal infection,FALSE,,
chlorogenic-acid,Launched,antioxidant,SLC37A4,neurology/psychiatry|pulmonary|allergy,headache|chest congestion|allergic rhinitis,FALSE,,
chlorpropamide,Launched,ATP channel blocker,ABCC8|KCNJ10,endocrinology,diabetes mellitus,FALSE,,
chlorpyrifos,Launched,acetylcholinesterase inhibitor,ACHE,,,FALSE,,
chlorquinaldol,Launched,other antibiotic,,infectious disease,fungal infection,FALSE,,
chromium-picolinate,Launched,insulin sensitizer,,endocrinology,diabetes mellitus,FALSE,,
chromocarb,Launched,antispasmodic,,,,FALSE,,
CI-844,Phase 2,,,,,FALSE,,
cibenzoline,Launched,sodium channel blocker,,cardiology,cardiac arrythmia,FALSE,,
CID-5458317,Preclinical,MAP kinase phosphatase inhibitor,MAPK3,,,FALSE,,
cilostamide,Preclinical,phosphodiesterase inhibitor,PDE3A|PDE3B,,,FALSE,,
cinalukast,Phase 2,leukotriene receptor antagonist,CYSLTR1,,,FALSE,,
cinnarazine,Launched,calcium channel blocker,,neurology/psychiatry|gastroenterology|ophthalmology,Meniere's disease|nausea|vomiting|Cogan's syndrome,FALSE,,
cinromide,Phase 3,,,,,FALSE,,
CL-218872,Phase 1,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,,,FALSE,,
clebopride,Launched,dopamine receptor antagonist,ACHE|DRD2,gastroenterology,nausea,FALSE,,
clenbuterol,Launched,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,pulmonary,chronic obstructive pulmonary disease (COPD)|asthma,FALSE,,
clobutinol,Withdrawn,antitussive,,,,FALSE,,
clocortolone-pivalate,Launched,steroid,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses,FALSE,,
clofazimine,Launched,GK0582 inhibitor,,infectious disease,leprosy,FALSE,,
clofoctol,Launched,protein synthesis inhibitor,,infectious disease,gram-positive bacterial infections,FALSE,,
clopamide,Launched,sodium/chloride cotransporter inhibitor,,cardiology,hypertension,FALSE,,
CMPD-1,Preclinical,p38 MAPK inhibitor,GNRHR|MAPK14,,,FALSE,,
cobicistat,Launched,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1),FALSE,,
colforsin-daproate,Launched,adenylyl cyclase activator,,,,FALSE,,
colfosceril-palmitate,Launched,pulmonary surfactant,,pulmonary,respiratory distress syndrome (RDS),FALSE,,
combretastatin-A-4,Phase 2,tubulin polymerization inhibitor,,,,FALSE,,
CPP,Phase 2,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,,FALSE,,
CR8-(R),Preclinical,CDK inhibitor,CCNA2,,,FALSE,,
creatine,Launched,,CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8,,,FALSE,,
cromakalim,Phase 2,,KCNJ8,,,FALSE,,
CS-110266,Preclinical,dopamine receptor agonist,SLC6A3,,,FALSE,,
cyclovalone,Launched,breast cancer resistance protein inhibitor,ABCG2,gastroenterology,bile stimulation,FALSE,,
cyromazine,Launched,,,,,FALSE,,
cytidine,Launched,,,,,FALSE,,
cytochalasin-B,Phase 2,microtubule inhibitor,ACTB,,,FALSE,,
cytochlor,Phase 1,,,,,FALSE,,
D-64131,Preclinical,microtubule inhibitor,TUBB,,,FALSE,,
D-7193,Phase 2,,,,,FALSE,,
danazol,Launched,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,obstetrics/gynecology|cardiology,endometriosis|angioedema,FALSE,,
dapivirine,Phase 3,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,,,FALSE,,
darapladib,Phase 3,phospholipase inhibitor,PLA2G7,,,FALSE,,
darifenacin,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,urology,urinary incontinence,FALSE,,
DCEBIO,Preclinical,potassium channel activator,KCNN2|KCNN3|KCNN4,,,FALSE,,
dehydrocholate-acid,Preclinical,,,,,FALSE,,
demecarium,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,ophthalmology,intraocular pressure|glaucoma,FALSE,,
deoxycorticosterone-acetate,Preclinical,progestogen hormone,NR3C2,,,FALSE,,
dequalinium,Launched,PKC inhibitor,KCNN1|KCNN3,infectious disease,first-aid antiseptic,FALSE,,
desoxycortone,Preclinical,mineralocorticoid receptor agonist,NR3C1|NR3C2,,,FALSE,,
dianhydrogalactitol,Phase 3,DNA alkylating agent,,,,FALSE,,
diaveridine,Launched,dihydrofolate reductase inhibitor,,infectious disease,coccidiosis,FALSE,,
dichlorisone-acetate,Phase 2,,,,,FALSE,,
dichloroacetate,Phase 3,pyruvate dehydrogenase kinase inhibitor,,,,FALSE,,
dichlorvos,Launched,acetylcholinesterase inhibitor,,,,FALSE,,
dicycloverine,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,gastroenterology,irritable bowel syndrome,FALSE,,
difluprednate,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology,endogenous uveitis,FALSE,,
digitoxigenin,Preclinical,ATPase inhibitor,ATP1A1,,,FALSE,,
digoxigenin,Preclinical,steroid,,,,FALSE,,
dihydroergocristine,Launched,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,neurology/psychiatry,senile dementia|cerebrovascular insufficiency,FALSE,,
dimethisoquin,Launched,local anesthetic,,neurology/psychiatry,local anesthetic,FALSE,,
diphemanil,Launched,acetylcholine receptor antagonist,CHRM3,neurology/psychiatry,spasms,FALSE,,
diphenyleneiodonium,Preclinical,nitric oxide synthase inhibitor,NOS2|NOS3,,,FALSE,,
dirithromycin,Launched,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bronchitis,FALSE,,
DMH1,Preclinical,ALK tyrosine kinase receptor inhibitor,ACVR1,,,FALSE,,
domiphen,Preclinical,,,,,FALSE,,
DPI-201106,Phase 2,sodium channel activator,ADRB2,,,FALSE,,
D-serine,Launched,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,,,FALSE,,
DU-728,Phase 1,structural glycoprotein antagonist,ITGA2B|ITGB3,,,FALSE,,
DVD-111,Phase 2,,,,,FALSE,,
ebastine,Launched,histamine receptor antagonist,CYP3A4|HRH1,allergy,allergic rhinitis|urticaria,FALSE,,
ecamsule-triethanolamine,Launched,,,dermatology,skin protectant|sunscreen lotion,FALSE,,
EMD-53998,Phase 1,phosphodiesterase inhibitor,TNNC1,,,FALSE,,
endo-IWR-1,Preclinical,PARP inhibitor,TNKS|TNKS2,,,FALSE,,
enocitabine,Launched,DNA synthesis inhibitor,CMPK1|RRM1|TYMS,hematologic malignancy,acute myeloid leukemia (AML),FALSE,,
enoximone,Launched,phosphodiesterase inhibitor,PDE3A,cardiology,congestive heart failure,FALSE,,
epiandrosterone,Preclinical,steroid,G6PD,,,FALSE,,
epinastine,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,FALSE,,
eprinomectin,Launched,benzodiazepine receptor agonist,,infectious disease,gastrointestinal roundworms|lungworms,FALSE,,
eprobemide,Launched,monoamine oxidase inhibitor,MAOA,neurology/psychiatry,depression,FALSE,,
eptifibatide,Launched,platelet aggregation inhibitor,ITGA2B|ITGB3,cardiology,acute coronary syndrome (ACS)|percutaneous coronary intervention (PCI),FALSE,,
equol,Launched,estrogen receptor agonist,ESR1|ESR2,,,FALSE,,
ER-27319,Preclinical,mediator release inhibitor|SYK inhibitor,SYK,,,FALSE,,
ercalcitriol,Phase 1,vitamin D receptor agonist,VDR,,,FALSE,,
erythritol,Launched,,,,,FALSE,,
estradiol-benzoate,Preclinical,contraceptive agent,ESR1,,,FALSE,,
estradiol-cypionate,Launched,estrogen receptor agonist,ESR1,endocrinology,hypoestrogenism|menopause,FALSE,,
ethacridine-lactate-monohydrate,Preclinical,DNA intercalating agent,,,,FALSE,,
etofylline-clofibrate,Launched,platelet aggregation inhibitor,PPARA,endocrinology,hyperlipidemia,FALSE,,
ETP-46464,Preclinical,ATR kinase inhibitor,,,,FALSE,,
EVP4593,Preclinical,NFkB pathway inhibitor,,,,FALSE,,
fenaclon,Preclinical,,,,,FALSE,,
fendiline,Preclinical,calcium channel blocker,HTR2B,,,FALSE,,
FERb-033,Preclinical,EGFR inhibitor,ERBB2,,,FALSE,,
fexinidazole,Phase 3,,,,,FALSE,,
finafloxacin,Launched,bacterial DNA gyrase inhibitor,,infectious disease|pulmonary,intra-abdominal infections|chronic obstructive pulmonary disease (COPD)|cystic fibrosis,FALSE,,
FK-3311,Phase 2,cyclooxygenase inhibitor,PTGS2,,,FALSE,,
FK-888,Phase 2,tachykinin antagonist,TACR1|TACR2,,,FALSE,,
FLI-06,Preclinical,notch signaling inhibitor,,,,FALSE,,
florfenicol,Launched,protein synthesis inhibitor,,pulmonary,bovine respiratory disease (BRD),FALSE,,
fludroxycortide,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,infectious disease|dermatology,skin infections|psoriasis,FALSE,,
flufenamic-acid,Preclinical,chloride channel blocker,AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5,,,FALSE,,
flumethasone,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,otolaryngology|infectious disease|dermatology,otitis|ear infections|corticosteroid-responsive dermatoses,FALSE,,
flumethasone-pivalate,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,allergy,allergic rhinitis,FALSE,,
fluorometholone,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology,eye inflammation,FALSE,,
fluoromethylcholine,Launched,,,,,FALSE,,
fluroxene,Preclinical,local anesthetic,,,,FALSE,,
forodesine,Launched,purinergic receptor antagonist,PNP,hematologic malignancy,peripheral T-cell lymphoma (PTCL),FALSE,,
forskolin,Launched,adenylyl cyclase activator,ADCY2|ADCY5|GNAS,,,FALSE,,
fosbretabulin,Phase 3,tubulin polymerization inhibitor|VE-cadherin antagonist,CDH5,,,FALSE,,
foscarnet,Launched,DNA polymerase inhibitor,,infectious disease,cytomegalovirus retinitis|acquired immunodeficiency syndrome (AIDS)|virus herpes simplex (HSV),FALSE,,
FPH1-(BRD-6125),Preclinical,hepatocyte function enhancer,,,,FALSE,,
FR-122047,Preclinical,cyclooxygenase inhibitor,,,,FALSE,,
FR-139317,Phase 1,endothelin receptor antagonist,EDNRA,,,FALSE,,
frentizole,Phase 1,immunosuppressant,,,,FALSE,,
fudosteine,Launched,mucolytic agent,,pulmonary,chest congestion,FALSE,,
G-1,Preclinical,G protein-coupled receptor agonist,GPER1,,,FALSE,,
gambogic-acid,Phase 2,caspase activator,BCL2,,,FALSE,,
gamma-aminobutyric-acid,Preclinical,benzodiazepine receptor agonist,GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1,,,FALSE,,
gastrodin,Phase 2,,,,,FALSE,,
gestrinone,Launched,progesterone receptor antagonist,AR|ESR1|PGR,obstetrics/gynecology,endometriosis,FALSE,,
GGTI-298,Preclinical,GGTase inhibitor,CDKN1A,,,FALSE,,
golgicide-A,Preclinical,ARF inhibitor,GBF1,,,FALSE,,
GS-39783,Preclinical,GABA receptor modulator,GABBR1,,,FALSE,,
GSK-3-inhibitor-IX,Preclinical,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,GSK3A|GSK3B,,,FALSE,,
GTP-14564,Preclinical,FLT3 inhibitor|tyrosine kinase inhibitor,CSF1R|FLT3|KIT|PDGFRB,,,FALSE,,
guanidine,Launched,HSP inhibitor,ALDH2|DLG4|GAMT|RNASE1,neurology/psychiatry,Lambert-Eaton myasthenic syndrome (LEMS),FALSE,,
GW-405833,Preclinical,cannabinoid receptor agonist,CNR2,,,FALSE,,
GW-583340,Preclinical,EGFR inhibitor,EGFR|ERBB2,,,FALSE,,
halcinonide,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,FALSE,,
halobetasol-propionate,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses,FALSE,,
halofuginone,Launched,collagenase inhibitor,COL1A1|MMP2,rheumatology,scleroderma,FALSE,,
harringtonine,Phase 3,protein synthesis inhibitor,,,,FALSE,,
hexachlorophene,Launched,potassium channel activator,GLUD1|SDHD,infectious disease,gram-positive bacterial infections,FALSE,,
hexaminolevulinate,Launched,,,radiology,diagnostic agent,FALSE,,
hexylresorcinol,Launched,local anesthetic,TYR,infectious disease,skin infections|first-aid antiseptic,FALSE,,
homoquinolinic-acid,Preclinical,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,,FALSE,,
homosalate,Preclinical,HSP inducer,,,,FALSE,,
"hydroxytacrine-maleate-(R,S)",Preclinical,cholinesterase inhibitor,ACHE,,,FALSE,,
hyodeoxycholic-acid,Phase 1,atherosclerosis formation inhibitor,,,,FALSE,,
hyoscyamine,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,gastroenterology|urology|neurology/psychiatry|allergy,peptic ulcer disease (PUD)|acute abdominal visceral spasm|ulcerative colitis|interstitial cystitis (IC)|enterocolitis|irritable bowel syndrome|tremors|allergic rhinitis,FALSE,,
hypericin,Phase 3,tyrosine kinase inhibitor,,,,FALSE,,
hypoestoxide,Phase 1,IKK inhibitor,IKBKB|IL1B|TNF,,,FALSE,,
ICI-162846,Phase 1,histamine receptor antagonist,HRH2,,,FALSE,,
idazoxan,Phase 3,adrenergic receptor antagonist,ADRA2A|PTGS2,,,FALSE,,
IDRA-21,Preclinical,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4,,,FALSE,,
IEM1754,Preclinical,glutamate receptor antagonist,GRIA1,,,FALSE,,
IKK-2-inhibitor-V,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,,,FALSE,,
imidapril,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure,FALSE,,
imiloxan,Phase 1,adrenergic receptor antagonist,ADRA2A|ADRA2B,,,FALSE,,
indoprofen,Withdrawn,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,,,FALSE,,
INH1,Preclinical,Hec1 inhibitor,NDC80,,,FALSE,,
inosine,Launched,neurotrophic agent,PARP1|PNP,,,FALSE,,
iobenguane,Launched,antineoplastic agent,,oncology|cardiology|endocrinology,neuroblastoma|congestive heart failure|pheochromocytoma,FALSE,,
iodipamide,Launched,radiopaque medium,ALB,radiology,contrast agent,FALSE,,
iododexetimide,Phase 2,acetylcholine receptor antagonist,,,,FALSE,,
IOWH032,Phase 2,CFTR channel antagonist,CFTR,,,FALSE,,
iproniazid,Withdrawn,monoamine oxidase inhibitor,MAOA|MAOB,,,FALSE,,
ipsapirone,Phase 3,serotonin receptor agonist,HTR1A,,,FALSE,,
isoetharine,Launched,adrenergic receptor agonist,,pulmonary,bronchospasm|asthma,FALSE,,
isofloxythepin,Phase 2,dopamine receptor antagonist,,,,FALSE,,
isoflupredone-acetate,Preclinical,,NR3C1,,,FALSE,,
isometheptene-mucate,Launched,,,neurology/psychiatry,headache,FALSE,,
isopropyl-myristate,Launched,,,dermatology,cosmetic,FALSE,,
isoxsuprine,Launched,adrenergic receptor agonist,ADRB2,rheumatology|cardiology,Raynaud's disease|arteriosclerosis|Buerger's disease,FALSE,,
JIB04,Preclinical,histone lysine demethylase inhibitor,KDM4E,,,FALSE,,
josamycin,Launched,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bronchitis,FALSE,,
JTE-607,Phase 2,cytokine production inhibitor,IL10|IL1B|IL6|TNF,,,FALSE,,
K-858,Preclinical,kinesin-like spindle protein inhibitor,KIF11,,,FALSE,,
KD-023,Phase 2,ACAT inhibitor,ACACA|ACACB,,,FALSE,,
kenpaullone,Preclinical,CDK inhibitor|glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,,,FALSE,,
KF-38789,Preclinical,P selectin inhibitor,SELP,,,FALSE,,
kifunensine,Phase 1,mannosidase inhibitor,MAN1B1|MAN2A1,,,FALSE,,
KP-1212,Phase 2,,,,,FALSE,,
K-Ras(G12C)-inhibitor-6,Preclinical,K-Ras inhibitor,,,,FALSE,,
K-strophanthidin,Phase 2,ATPase inhibitor,ATP1A1,,,FALSE,,
kynurenic-acid,Phase 1,glutamate receptor antagonist,GPR35|GRIN1|GRIN2A|GRIN2B,,,FALSE,,
L-798106,Preclinical,prostanoid receptor antagonist,PTGER3,,,FALSE,,
lacitol,Launched,laxative,,gastroenterology,constipation,FALSE,,
lanatoside-C,Preclinical,cardiac glycoside,,,,FALSE,,
lanoconazole,Launched,sterol demethylase inhibitor,,infectious disease,fungal infection,FALSE,,
lasalocid,Launched,bacterial permeability inducer,,infectious disease,coccidiosis,FALSE,,
latanoprost,Launched,prostanoid receptor agonist,PTGFR,ophthalmology,ocular hypertension|glaucoma,FALSE,,
LB42708,Preclinical,farnesyltransferase inhibitor,,,,FALSE,,
LE-135,Preclinical,retinoid receptor agonist,RARB,,,FALSE,,
lerisetron,Phase 3,serotonin receptor antagonist,HTR3A,,,FALSE,,
levobunolol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,ophthalmology,glaucoma|ocular hypertension,FALSE,,
levocarnitine,Launched,,CRAT|CROT,endocrinology,carnitine deficiency,FALSE,,
licochalcone-A,Phase 3,topoisomerase inhibitor,PTPN1,,,FALSE,,
lidamidine,Launched,adrenergic receptor agonist,,gastroenterology,diarrhea,FALSE,,
lidocaine,Launched,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,neurology/psychiatry|dermatology|hematology,itching|eczema|hemorrhage,FALSE,,
linalool,Phase 1,anticonvulsant,,,,FALSE,,
lomitapide,Launched,microsomal trigylceride transfer protein inhibitor,MTTP,endocrinology,hypercholesterolemia,FALSE,,
loxistatin-acid,Preclinical,cysteine peptidase inhibitor,CTSB,,,FALSE,,
lurasidone,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,neurology/psychiatry,schizophrenia,FALSE,,
LY2183240,Preclinical,FAAH inhibitor|FAAH reuptake inhibitor,FAAH,,,FALSE,,
LY303511,Preclinical,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,BRD2|BRD3|BRD4,,,FALSE,,
LY364947,Preclinical,p38 MAPK inhibitor|TGF beta receptor inhibitor,TGFBR1,,,FALSE,,
LY456236,Preclinical,glutamate receptor antagonist,GRM1,,,FALSE,,
maxacalcitol,Launched,vitamin D receptor agonist,VDR,endocrinology,hyperparathyroidism,FALSE,,
mefexamide,Preclinical,psychoactive drug,,,,FALSE,,
meglitinide,Phase 2,potassium channel blocker,CCR2,,,FALSE,,
MEK1-2-inhibitor,Preclinical,MEK inhibitor,MAP2K2,,,FALSE,,
melengestrol-acetate,Preclinical,progesterone receptor agonist,,,,FALSE,,
mephenytoin,Launched,hydantoin antiepileptic,SCN5A,neurology/psychiatry,seizures,FALSE,,
mepivacaine,Launched,potassium channel blocker|sodium channel blocker,,neurology/psychiatry,local anesthetic,FALSE,,
mericitabine,Phase 2,HCV inhibitor,,,,FALSE,,
merimepodib,Phase 2,inosine monophosphate dehydrogenase inhibitor,IMPDH1,,,FALSE,,
mesoridazine,Launched,dopamine receptor antagonist,DRD2|HTR2A,neurology/psychiatry,schizophrenia,FALSE,,
metaraminol,Launched,adrenergic receptor agonist,ADRA1A,cardiology,hypotension,FALSE,,
metatinib,Phase 1,Bcr-Abl kinase inhibitor,ABL1|BCR,,,FALSE,,
methiazole,Preclinical,anthelmintic agent,,,,FALSE,,
methoxyflurane,Launched,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1,neurology/psychiatry,general anaesthetic,FALSE,,
metoxibutropate,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,,,FALSE,,
metyrapone,Launched,cytochrome P450 inhibitor,CYP11B1,nephrology,adrenal diagnostic agent,FALSE,,
mexeneone,Preclinical,,,,,FALSE,,
mexiletine,Launched,sodium channel blocker,PLAU|SCN4A|SCN5A,cardiology,ventricular arrhythmias|ventricular tachycardia (VT),FALSE,,
mibampator,Phase 2,glutamate receptor modulator,GRIA1,,,FALSE,,
mibefradil,Withdrawn,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,,,FALSE,,
midodrine,Launched,adrenergic receptor agonist,,cardiology,hypotension,FALSE,,
MK-0773,Phase 2,androgen receptor modulator,AR,,,FALSE,,
MK-8745,Preclinical,Aurora kinase inhibitor,AURKA,,,FALSE,,
ML133,Preclinical,potassium channel blocker,,,,FALSE,,
mozavaptan,Launched,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,endocrinology,hyponatremia,FALSE,,
MRS-1220,Preclinical,adenosine receptor antagonist,ADORA2B|ADORA3,,,FALSE,,
MTPG,Preclinical,glutamate receptor antagonist,GRM2|GRM3,,,FALSE,,
N-acetylmannosamine,Phase 2,,,,,FALSE,,
nadide,Launched,free radical scavenger,AHCY|AKR1A1|ALDH2|BLVRA|DHPS|DLD|GALE|HMGCR|HSD17B1|HSD17B4|IMPDH2|MGAM|P2RY11|SORD|TRPM2,,,FALSE,,
nadifloxacin,Launched,bacterial DNA gyrase inhibitor,,dermatology|infectious disease,acne vulgaris (AV)|skin infections,FALSE,,
nafcillin,Launched,bacterial cell wall synthesis inhibitor,CYP1A2|CYP3A4|SLC22A6,infectious disease,gram-positive bacterial infections,FALSE,,
naftidrofuryl,Launched,adrenergic receptor antagonist,,cardiology,claudication,FALSE,,
naftifine,Launched,fungal squalene epoxidase inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis,FALSE,,
naloxone,Launched,opioid receptor antagonist,CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4,pulmonary,respiratory depression,FALSE,,
NAN-190,Preclinical,serotonin receptor agonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1F,,,FALSE,,
narasin,Launched,antiprotozoal agent,,infectious disease,coccidiosis,FALSE,,
narlaprevir,Phase 3,HCV inhibitor,,,,FALSE,,
navarixin,Phase 2,CC chemokine receptor antagonist,CXCR1|CXCR2,,,FALSE,,
nemonapride,Launched,dopamine receptor antagonist,DRD2|DRD3|DRD4,neurology/psychiatry,schizophrenia,FALSE,,
nexturastat-A,Preclinical,HDAC inhibitor,HDAC1|HDAC6,,,FALSE,,
NH125,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,,,FALSE,,
nicotine,Launched,acetylcholine receptor agonist,CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1,neurology/psychiatry,smoking cessation,FALSE,,
niridazole,Launched,phosphofructokinase inhibitor,,infectious disease,schistosomiasis,FALSE,,
nisoxetine,Phase 1,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,,,FALSE,,
nitarsone,Launched,,,dermatology,blackhead disease,FALSE,,
nithiamide,Preclinical,bacterial DNA inhibitor,,,,FALSE,,
nitrocaramiphen,Preclinical,cholinergic receptor antagonist,CHRM1,,,FALSE,,
nizatidine,Launched,histamine receptor antagonist,HRH2,gastroenterology,duodenal ulcer disease|erosive esophagitis (EE)|ulcerative esophagitis (UE)|gastroesophageal reflux disease (GERD),FALSE,,
nizofenone,Launched,ion channel antagonist,,neurology/psychiatry,stroke,FALSE,,
NMS-E973,Preclinical,HSP inhibitor,,,,FALSE,,
nobiletin,Preclinical,MEK inhibitor,MAP2K1,,,FALSE,,
nomegestrol-acetate,Launched,progesterone receptor agonist,PGR,endocrinology,contraceptive,FALSE,,
nonoxynol-9,Launched,membrane integrity inhibitor,,endocrinology,contraceptive,FALSE,,
norethindrone,Launched,progesterone receptor agonist,PGR,obstetrics/gynecology,endometriosis,FALSE,,
norethindrone-acetate,Launched,progesterone receptor agonist,PGR,endocrinology|orthopedics|obstetrics/gynecology,menopause|osteoporosis|vaginal atrophy,FALSE,,
noretynodrel,Launched,progestogen hormone,PGR,endocrinology,contraceptive,FALSE,,
NSC-3852,Preclinical,HDAC inhibitor,HDAC1,,,FALSE,,
NSC-632839,Preclinical,ubiquitin specific protease inhibitor,SENP2|USP1|USP2|USP7,,,FALSE,,
NSC-697923,Preclinical,ubiquitin-conjugating enzyme inhibitor,UBE2N,,,FALSE,,
NVP-BVU972,Preclinical,MET inhibitor,MET,,,FALSE,,
obidoxime,Launched,cholinesterase reactivator,ACHE,critical care|neurology/psychiatry,poison antidote|nerve gas poisoning,FALSE,,
octenidine,Launched,membrane integrity inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,FALSE,,
octopamine,Preclinical,trace amine associated receptor agonist,F10|TAAR1,,,FALSE,,
OLDA,Preclinical,TRPV agonist,GPR119,,,FALSE,,
oleoylethanolamide,Preclinical,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,CNR1|GPR119|GPR55|PPARA,,,FALSE,,
oncrasin-1,Preclinical,apoptosis stimulant,,,,FALSE,,
orotic-acid,Phase 2,,DHODH,,,FALSE,,
oxiperomide,Phase 2,dopamine receptor antagonist,,,,FALSE,,
oxiracetam,Launched,acetylcholine receptor agonist,,neurology/psychiatry,senile dementia,FALSE,,
oxprenolol,Launched,adrenergic receptor antagonist,ADRB1,cardiology,angina pectoris|hypertension|cardiac arrythmia,FALSE,,
oxyphencyclimine,Launched,cholinergic receptor antagonist,,gastroenterology,peptic ulcer disease (PUD),FALSE,,
oxyquinoline,Launched,chelating agent,METAP2,dermatology,cosmetic,FALSE,,
P22077,Preclinical,ubiquitin specific protease inhibitor,USP7,,,FALSE,,
P5091,Preclinical,ubiquitin specific protease inhibitor,USP7,,,FALSE,,
paliperidone,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,neurology/psychiatry,schizophrenia,FALSE,,
palmatine-chloride,Preclinical,dopamine synthesis inhibitor,CYP3A4,,,FALSE,,
palmitoylethanolamide,Launched,cannabinoid receptor agonist,CNR2|GPR119|GPR55,,,FALSE,,
parachlorophenol,Launched,antiinfective drug,,infectious disease,first-aid antiseptic,FALSE,,
pardoprunox,Phase 3,dopamine receptor agonist|serotonin receptor agonist,DRD2|DRD3|DRD4|HTR1A|HTR7,,,FALSE,,
PD-407824,Preclinical,PKC inhibitor,WEE1,,,FALSE,,
penfluridol,Launched,T-type calcium channel blocker,CACNA1G,neurology/psychiatry,schizophrenia,FALSE,,
peruvoside,Phase 1,cardiac glycoside,,,,FALSE,,
PETCM,Preclinical,caspase activator,CASP3,,,FALSE,,
PF-04136309,Phase 2,CC chemokine receptor antagonist,,,,FALSE,,
PF-4981517,Preclinical,cytochrome P450 inhibitor,CYP3A4,,,FALSE,,
PFK-015,Phase 1,phosphofructokinase inhibitor,PFKFB3,,,FALSE,,
phenazone,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief,FALSE,,
phenylbutazone,Withdrawn,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,,,FALSE,,
phenylmercuric-acetate,Preclinical,other antifungal,,,,FALSE,,
PI-828,Preclinical,PI3K inhibitor,,,,FALSE,,
pibenzimol,Phase 2,DNA inhibitor,,,,FALSE,,
pilocarpine,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,ophthalmology|cardiology,glaucoma|hypertension,FALSE,,
pindolol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,cardiology,hypertension,FALSE,,
piperacetazine,Launched,dopamine receptor antagonist,,neurology/psychiatry,schizophrenia,FALSE,,
pirenperone,Preclinical,serotonin receptor antagonist,HTR2A|HTR7,,,FALSE,,
piretanide,Launched,glucocorticoid receptor agonist,SLC12A1|SLC12A2,cardiology,hypertension|edema,FALSE,,
pitolisant,Launched,histamine receptor antagonist,HRH3,,,FALSE,,
PJ-34,Preclinical,PARP inhibitor,EEF2|PARP1|PARP15|PARP3,,,FALSE,,
PKI-179,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR,,,FALSE,,
PP-1,Preclinical,SRC inhibitor,HCK|RET,,,FALSE,,
PP-2,Preclinical,SRC inhibitor,ABL1|LCK|RIPK2|SRC,,,FALSE,,
PPT,Preclinical,estrogen receptor agonist,ESR1,,,FALSE,,
PQ-401,Preclinical,IGF-1 inhibitor,IGF1R,,,FALSE,,
PR-619,Preclinical,DUB inhibitor,,,,FALSE,,
practolol,Withdrawn,adrenergic receptor antagonist,ADRB1,,,FALSE,,
pranidipine,Phase 2,calcium channel blocker,CACNA1C,,,FALSE,,
prednisolone-hemisuccinate,Preclinical,glucocorticoid receptor agonist,NR3C1,,,FALSE,,
prednisolone-tebutate,Launched,anti-inflammatory agent,,,,FALSE,,
primaquine,Launched,antimalarial agent|DNA inhibitor,,infectious disease,malaria,FALSE,,
proflavine-hemisulfate,Phase 2,topical anesthetic,F2,,,FALSE,,
propoxycaine,Launched,local anesthetic,,neurology/psychiatry,anesthetic,FALSE,,
propranolol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,cardiology|neurology/psychiatry,hypertension|angina pectoris|migraine headache,FALSE,,
protirelin,Launched,thyrotropin releasing hormone receptor agonist,TRHR,radiology,thyroid function diagnostic,FALSE,,
PSB-1115,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,,,FALSE,,
PTC-209,Preclinical,BMI-1 inhibitor,,,,FALSE,,
pterostilbene,Phase 2/Phase 3,cyclooxygenase inhibitor|PPAR receptor agonist,PTGS2,,,FALSE,,
PU-H71,Phase 1,HSP inhibitor,HSP90AA1,,,FALSE,,
puromycin,Preclinical,protein synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,,,FALSE,,
pyrithione-zinc,Launched,ATP synthase inhibitor,KCNQ1|KCNQ2|KCNQ4|KCNQ5,dermatology,dandruff|cosmetic,FALSE,,
pyritinol,Launched,,,rheumatology|neurology/psychiatry,rheumatoid arthritis|senile dementia,FALSE,,
quinethazone,Launched,thiazide diuretic,,cardiology,hypertension,FALSE,,
R306465,Phase 1,HDAC inhibitor,,,,FALSE,,
raclopride,Launched,dopamine receptor antagonist,DRD2|DRD3|HTR1A,,,FALSE,,
radezolid,Phase 2,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,,,FALSE,,
ramifenazone,Launched,cyclooxygenase inhibitor,,neurology/psychiatry|endocrinology,pain relief|fever,FALSE,,
remoxipride,Withdrawn,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|SIGMAR1,,,FALSE,,
RG2833,Phase 1,HDAC inhibitor,HDAC1|HDAC3,,,FALSE,,
RGFP966,Preclinical,HDAC inhibitor,HDAC3,,,FALSE,,
RI-1,Preclinical,,RAD51,,,FALSE,,
rimexolone,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,ophthalmology,anterior uveitis,FALSE,,
RN-1734,Preclinical,TRPV antagonist,TRPV4,,,FALSE,,
Ro-04-5595,Preclinical,glutamate receptor antagonist,GRIN2B,,,FALSE,,
Ro-10-5824,Preclinical,dopamine receptor agonist,DRD4,,,FALSE,,
Ro-106-9920,Preclinical,NFkB pathway inhibitor,,,,FALSE,,
Ro-90-7501,Preclinical,beta amyloid protein neurotoxicity inhibitor,APP,,,FALSE,,
Ro-9187,Preclinical,HCV inhibitor,,,,FALSE,,
RS-16566,Preclinical,serotonin receptor antagonist,,,,FALSE,,
RS-17053,Preclinical,adrenergic receptor antagonist,ADRA1A|ADRA1D,,,FALSE,,
RS-504393,Preclinical,CC chemokine receptor antagonist,CCL2|CCR2,,,FALSE,,
RS-67506,Preclinical,serotonin receptor partial agonist,HTR4,,,FALSE,,
RU-58841,Phase 2,androgen receptor antagonist,AR,,,FALSE,,
rubitecan,Phase 3,topoisomerase inhibitor,TOP1,,,FALSE,,
rucinol,Phase 1,tyrosinase inhibitor,TYR,,,FALSE,,
rutin,Launched,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,rheumatology|otolaryngology|gastroenterology|neurology/psychiatry|allergy,joint pain|nasal congestion|constipation|irritability|allergic rhinitis,FALSE,,
ryuvidine,Preclinical,histone lysine methyltransferase inhibitor,CDK2|CDK4,,,FALSE,,
S26948,Preclinical,PPAR receptor agonist,PPARG,,,FALSE,,
salvianolic-acid-B,Phase 2,EGFR inhibitor|metalloproteinase inhibitor,MMP9,,,FALSE,,
salvinorin-A,Phase 1,opioid receptor agonist,OPRD1|OPRK1|OPRM1,,,FALSE,,
sangivamycin,Phase 1,DNA inhibitor,,,,FALSE,,
satraplatin,Phase 3,DNA alkylating agent,,,,FALSE,,
SB-200646,Preclinical,serotonin receptor antagonist,HTR2B|HTR2C,,,FALSE,,
SB-205384,Preclinical,GABA receptor modulator,GABRA3|GABRA5|GABRA6,,,FALSE,,
SB-216641,Preclinical,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,,,FALSE,,
SB-218078,Preclinical,CHK inhibitor,CHEK1,,,FALSE,,
SB-218795,Preclinical,tachykinin antagonist,TACR3,,,FALSE,,
SB-225002,Preclinical,CC chemokine receptor antagonist,CXCR2,,,FALSE,,
SB-228357,Preclinical,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,,,FALSE,,
SB-2343,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,,,FALSE,,
SB-366791,Preclinical,TRPV antagonist,TRPV1,,,FALSE,,
SB-657510,Preclinical,urotensin receptor antagonist,UTS2R,,,FALSE,,
SC-144,Preclinical,P glycoprotein inhibitor,,,,FALSE,,
SCH-58261,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,,FALSE,,
scriptaid,Preclinical,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,,FALSE,,
SCS,Preclinical,,,,,FALSE,,
SDZ-WAG-994,Phase 2,adenosine receptor agonist,ADORA1,,,FALSE,,
securinine,Preclinical,GABA receptor antagonist|TP53 activator,GABRA1,,,FALSE,,
selamectin,Launched,nematocide,,infectious disease,flea control,FALSE,,
Se-methylselenocysteine,Phase 2,,,,,FALSE,,
sertindole,Withdrawn,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,,,FALSE,,
sevoflurane,Launched,membrane integrity inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1,neurology/psychiatry,anesthetic,FALSE,,
SGI-1027,Preclinical,DNA methyltransferase inhibitor,DNMT1|DNMT3A|DNMT3B,,,FALSE,,
SIB-1757,Preclinical,glutamate receptor antagonist,GRM5,,,FALSE,,
skepinone-L,Preclinical,p38 MAPK inhibitor,MAPK14,,,FALSE,,
SKF-96365,Preclinical,calcium channel blocker,CYP3A4|PKD2|TRPC1|TRPC3|TRPC4|TRPC5|TRPV2,,,FALSE,,
S-methylcysteine,Phase 1,,CTSD|MGMT,,,FALSE,,
sobetirome,Phase 1/Phase 2,thyroid hormone receptor agonist,THRA|THRB,,,FALSE,,
sodium-stibogluconate,Launched,tyrosine phosphatase inhibitor,PTPN6,infectious disease,leishmaniasis,FALSE,,
sodium-tanshinone-II-A-sulfonate,Phase 2,potassium channel activator,,,,FALSE,,
spermine,Preclinical,,CA14|CA4|CA6|CA9|CASR|GRIN1|GRIN2A|KCNJ4|ODC1|SMOX|SMS|TRPM4|TRPM5,,,FALSE,,
spiradoline,Phase 2,opioid receptor agonist,OPRK1,,,FALSE,,
spironolactone,Launched,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,endocrinology|cardiology|gastroenterology|rheumatology,hyperaldosteronism|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|hypertension|hypokalemia,FALSE,,
SR-27897,Phase 2,CCK receptor antagonist,CCKAR,,,FALSE,,
SR-33805,Phase 1,calcium channel blocker,,,,FALSE,,
SR-57227A,Phase 2,serotonin receptor agonist,HTR3A,,,FALSE,,
stattic,Preclinical,,,,,FALSE,,
SU014813,Phase 2,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,,,FALSE,,
SU3327,Preclinical,JNK inhibitor,MAPK8,,,FALSE,,
sulconazole,Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis,FALSE,,
sulfabenzamide,Launched,bacterial antifolate,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,FALSE,,
sulfamethazine,Launched,PABA antagonist,,gastroenterology,enteritis,FALSE,,
sulmazole,Phase 1,adenosine receptor antagonist,,,,FALSE,,
suxibuzone,Launched,cyclooxygenase inhibitor,,rheumatology|neurology/psychiatry,joint pain|muscle pain,FALSE,,
tacalcitol,Launched,vitamin D receptor agonist,VDR,dermatology,psoriasis|chapped lips,FALSE,,
tagatose,Launched,phosphorylase inhibitor,PYGL,,,FALSE,,
TAK-632,Preclinical,RAF inhibitor,BRAF,,,FALSE,,
taltobulin,Phase 1,tubulin polymerization inhibitor,,,,FALSE,,
tanaproget,Phase 2,progesterone receptor agonist,PGR,,,FALSE,,
TAS-103,Phase 1,topoisomerase inhibitor,TOP1,,,FALSE,,
tasisulam,Phase 3,apoptosis stimulant,,,,FALSE,,
TC1,Preclinical,beta-secretase inhibitor,BACE1,,,FALSE,,
tecastemizole,Phase 3,histamine receptor antagonist,KCNH2,,,FALSE,,
tedizolid,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease,skin infections,FALSE,,
tedizolid-phosphate,Launched,protein synthesis inhibitor,,infectious disease,skin infections,FALSE,,
temoporfin,Launched,radical formation stimulant,,oncology,head and neck squamous cell carcinoma (HNSCC),FALSE,,
tenovin-6,Preclinical,SIRT inhibitor,SIRT1|SIRT2|SIRT3,,,FALSE,,
tepoxalin,Launched,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5,rheumatology|orthopedics,rheumatoid arthritis|hip dysplasia,FALSE,,
teprenone,Launched,mucus protecting agent,,dermatology,cosmetic,FALSE,,
terbutaline,Launched,adrenergic receptor agonist,ADRB2,pulmonary,bronchospasm|bronchitis|emphysema,FALSE,,
terconazole,Launched,sterol demethylase inhibitor,,infectious disease,vulvovaginal candidiasis,FALSE,,
teroxirone,Phase 1,DNA inhibitor,,,,FALSE,,
tetramethylthiuram-monosulfide,Preclinical,,,,,FALSE,,
tezacaftor,Launched,CFTR channel agonist,,pulmonary,cystic fibrosis,FALSE,,
TG-100572,Preclinical,SRC inhibitor|VEGFR inhibitor,KDR|SRC,,,FALSE,,
TG-100713,Preclinical,PI3K inhibitor,,,,FALSE,,
TH-302,Phase 3,DNA alkylating agent,,,,FALSE,,
thiamine,Launched,vitamin B,SLC19A2|SLC19A3|TPK1,metabolism,thiamine deficiency,FALSE,,
thiocolchicoside,Launched,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,neurology/psychiatry,muscle relaxant,FALSE,,
thiomersal,Launched,other antibiotic,OXCT1,infectious disease,preservative,FALSE,,
thioproperazine,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,neurology/psychiatry,schizophrenia,FALSE,,
thiostrepton,Launched,FOXM1 inhibitor|protein synthesis inhibitor,FOXM1,obstetrics/gynecology,mastitis,FALSE,,
thiram,Launched,,JAK2,ophthalmology,contact dermatitis,FALSE,,
thonzonium,Launched,ATPase inhibitor,,infectious disease,ear infections,FALSE,,
tilmicosin,Launched,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bovine respiratory disease (BRD),FALSE,,
tiludronate,Launched,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,orthopedics,navicular syndrome,FALSE,,
tiotidine,Phase 2,histamine receptor antagonist,HRH2,,,FALSE,,
tipranavir,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),FALSE,,
TMC-353121,Phase 2,RSV fusion inhibitor,,,,FALSE,,
TMS,Preclinical,,,,,FALSE,,
tofogliflozin,Launched,sodium/glucose cotransporter inhibitor,GCK,endocrinology,diabetes mellitus,FALSE,,
trans-4-hydroxycrotonic-acid,Preclinical,gamma hydroxybutyric acid ligand,,,,FALSE,,
trapidil,Launched,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,cardiology,coronary artery disease (CAD),FALSE,,
tremorine,Preclinical,acetylcholine receptor agonist,,,,FALSE,,
trequinsin,Phase 1,phosphodiesterase inhibitor,PDE5A,,,FALSE,,
triamterene,Launched,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,endocrinology|cardiology,hypokalemia|hypertension|edema,FALSE,,
triclabendazole,Launched,microtubule inhibitor,DNMT1,infectious disease,tapeworm,FALSE,,
trimebutine,Launched,opioid receptor agonist,OPRD1|OPRK1|OPRM1,gastroenterology,irritable bowel syndrome,FALSE,,
trolox,Launched,antioxidant,,,,FALSE,,
trometamol,Launched,,AMD1|CANT1|DCN|NEIL1|VEGFA,,,FALSE,,
trovafloxacin,Withdrawn,bacterial DNA gyrase inhibitor,TOP2A,,,FALSE,,
tryptanthrin,Preclinical,cyclooxygenase inhibitor,IDO1,,,FALSE,,
TU-2100,Phase 2,,,,,FALSE,,
tyrphostin-A9,Preclinical,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,,,,FALSE,,
tyrphostin-AG-1296,Preclinical,FLT3 inhibitor,FLT3,,,FALSE,,
tyrphostin-AG-494,Preclinical,EGFR inhibitor,EGFR,,,FALSE,,
tyrphostin-AG-99,Preclinical,tyrosine kinase inhibitor,EGFR,,,FALSE,,
U-18666A,Preclinical,oxidosqualene cyclase inhibitor,,,,FALSE,,
UH-232-(+),Preclinical,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR1A,,,FALSE,,
ulipristal,Launched,progesterone receptor antagonist,PGR,endocrinology,contraceptive,FALSE,,
uric-acid,Phase 3,,PYGL,,,FALSE,,
valnemulin,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease|gastroenterology,dysentry|colitis|pneumonia,FALSE,,
VER-49009,Preclinical,HSP inhibitor,HSP90AA1,,,FALSE,,
vincamine,Withdrawn,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,,,FALSE,,
VLX600,Phase 1,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,TP53|USP14,,,FALSE,,
VTP-27999,Phase 1,renin inhibitor,REN,,,FALSE,,
VU0238429,Preclinical,acetylcholine receptor allosteric modulator,CHRM5,,,FALSE,,
VU0361737,Preclinical,glutamate receptor positive allosteric modulator,GRM4,,,FALSE,,
VU0364770,Preclinical,glutamate receptor positive allosteric modulator,GRM4,,,FALSE,,
WAY-170523,Preclinical,metalloproteinase inhibitor,MMP13,,,FALSE,,
WP1130,Preclinical,deubiquitinase inhibitor,JAK2|UCHL5|USP14|USP9X,,,FALSE,,
xanomeline,Phase 3,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7,,,FALSE,,
XBD173,Phase 2,benzodiazepine receptor ligand,TSPO,,,FALSE,,
xilobam,Phase 1,,,,,FALSE,,
xylazine,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,neurology/psychiatry,anesthetic,FALSE,,
YM-976,Phase 1,phosphodiesterase inhibitor,PDE4A,,,FALSE,,
zardaverine,Phase 2,phosphodiesterase inhibitor,PDE4D,,,FALSE,,
ZK-93423,Phase 3,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,,,FALSE,,
ZK-93426,Phase 1,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,,,FALSE,,
ZLN005,Preclinical,,,,,FALSE,,
ZM-306416,Preclinical,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,,,FALSE,,
zolantidine,Preclinical,histamine receptor antagonist,,,,FALSE,,
betamethasone,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,TRUE,,
XL888,Phase 1,HSP inhibitor,,,,TRUE,,
metoprolol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,cardiology,hypertension|angina pectoris|myocardial infarction,TRUE,,
methscopolamine,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,gastroenterology,peptic ulcer disease (PUD),TRUE,,
terfenadine,Withdrawn,histamine receptor antagonist,HRH1|KCNH1|KCNH2,,,TRUE,,
diclazuril,Launched,antiprotozoal agent,,infectious disease,equine protozoal myeloencephalitis (EPM),TRUE,,
monensin,Launched,bacterial permeability inducer,,infectious disease,gastrointestinal parasites,TRUE,,
galeterone,Phase 3,androgen receptor modulator,AR|CYP17A1,,,TRUE,,
racecadotril,Launched,enkephalinase inhibitor,MME,gastroenterology,diarrhea,TRUE,,
cyclophosphamide,Launched,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7,hematologic malignancy|oncology,Hodgkin's lymphoma|small lymphocytic lymphoma (SLL)|breast cancer|neuroblastoma|Burkitt's lymphoma|multiple myeloma|chronic lymphocytic leukemia (CLL)|acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL)|chronic myeloid leukemia (CML)|true histiocytic lymphoma (THL)|retinoblastoma|ovarian cancer,TRUE,,
GSK429286A,Preclinical,rho associated kinase inhibitor,ROCK1,,,TRUE,,
carvedilol,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,cardiology,myocardial infarction|hypertension,TRUE,,
proscillaridin-A,Launched,,,cardiology,congestive heart failure|cardiac arrythmia,TRUE,,
nutlin-3,Preclinical,MDM inhibitor,MDM2|TP53,,,TRUE,,
pomalidomide,Launched,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,hematologic malignancy,multiple myeloma,TRUE,,
ornithine,Launched,NFkB pathway modulator,GPRC6A,,,TRUE,,
norgestrel,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1,endocrinology,contraceptive,TRUE,,
lenalidomide,Launched,anticancer agent,TNF,hematologic malignancy,multiple myeloma|mantle cell lymphoma (MCL)|myelodysplastic diseases (MDS),TRUE,,
itraconazole,Launched,cytochrome P450 inhibitor,,infectious disease,onychomycosis|histoplasmosis|blastomycosis|aspergillosis,TRUE,,
pheniramine,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria,TRUE,,
sclareol,Preclinical,,,,,TRUE,,
warfarin,Launched,vitamin K antagonist,VKORC1,hematology|cardiology,deep vein thrombosis (DVT)|pulmonary embolism (PE)|atrial fibrillation (AF)|myocardial infarction,TRUE,,
erastin,Preclinical,ion channel antagonist,VDAC2,,,TRUE,,
aminoglutethimide,Launched,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,endocrinology|oncology,Cushing's syndrome|breast cancer,TRUE,,
KI-16425,Preclinical,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,,,TRUE,,
emetine,Phase 2,protein synthesis inhibitor,RPS2,,,TRUE,,
zaldaride,Phase 3,calmodulin antagonist,CALM1,,,TRUE,,
formestane,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer,TRUE,,
lestaurtinib,Phase 3,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,FLT3|NTRK1,,,TRUE,,
prednisolone,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis,TRUE,,
salinomycin,Launched,,,infectious disease,coccidiosis,TRUE,,
bicalutamide,Launched,androgen receptor antagonist,AR,oncology,prostate cancer,TRUE,,
methocarbamol,Launched,muscle relaxant,CA1,neurology/psychiatry,muscle relaxant,TRUE,,
teniposide,Launched,topoisomerase inhibitor,TOP2A|TOP2B,hematologic malignancy,acute lymphoblastic leukemia (ALL),TRUE,,
bruceantin,Phase 2,protein synthesis inhibitor,,,,TRUE,,
oprozomib,Phase 1/Phase 2,proteasome inhibitor,,,,TRUE,,
ketoconazole,Launched,sterol demethylase inhibitor,KCNA10,dermatology,seborrheic dermatitis,TRUE,,
rabeprazole,Launched,ATPase inhibitor|gastrin inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|duodenal ulcer disease|Zollinger-Ellison syndrome,TRUE,,
teriflunomide,Launched,dihydroorotate dehydrogenase inhibitor,DHODH,neurology/psychiatry,multiple sclerosis,TRUE,,
WYE-125132,Preclinical,mTOR inhibitor,MTOR,,,TRUE,,
methacycline,Preclinical,protein synthesis inhibitor,,pulmonary,bronchitis,TRUE,,
ciprofibrate,Launched,PPAR receptor agonist,PPARA,endocrinology,hyperlipidemia,TRUE,,
meclizine,Launched,constitutive androstane receptor (CAR) agonist,NR1I3,gastroenterology|neurology/psychiatry,nausea|vomiting|motion sickness,TRUE,,
palomid-529,Phase 1,AKT inhibitor|mTOR inhibitor,MTOR,,,TRUE,,
halofantrine,Launched,antimalarial agent,KCNN4,infectious disease,malaria,TRUE,,
methotrexate,Launched,dihydrofolate reductase inhibitor,DHFR,oncology|hematologic malignancy|dermatology|rheumatology,gestational choriocarcinoma|hydatidiform mole|acute lymphoblastic leukemia (ALL)|psoriasis|rheumatoid arthritis,TRUE,,
omeprazole,Launched,ATPase inhibitor,ATP4A|CLCN2,gastroenterology,heartburn,TRUE,,
piroxicam,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis,TRUE,,
PD-318088,Preclinical,MEK inhibitor,,,,TRUE,,
oxymatrine,Launched,,,,,TRUE,,
amisulpride,Launched,dopamine receptor antagonist,DRD2,neurology/psychiatry,psychosis|bipolar disorder|schizophrenia,TRUE,,
ifosfamide,Launched,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,oncology|urology,testicular carcinoma|hemorrhagic cystitis,TRUE,,
lafutidine,Launched,histamine receptor antagonist,HRH2,gastroenterology,duodenal ulcer disease|peptic ulcer disease (PUD),TRUE,,
evodiamine,Preclinical,ATPase inhibitor|TRPV agonist,TRPV1,,,TRUE,,
echinomycin,Phase 2,DNA intercalating agent,,,,TRUE,,
minocycline,Launched,bacterial 30S ribosomal subunit inhibitor,,endocrinology|infectious disease|ophthalmology|urology,fever|respiratory tract infections|psittacosis|trachoma|conjunctivitis|urethritis|chancroid|tularemia|cholera|brucellosis,TRUE,,
secnidazole,Launched,acetylcholinesterase inhibitor|microtubule inhibitor,,infectious disease,protozoan infection,TRUE,,
estramustine,Launched,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,oncology,prostate cancer,TRUE,,
nanchangmycin,Preclinical,other antibiotic,,,,TRUE,,
ibutilide,Launched,potassium channel blocker,CACNA1C|KCNH2,cardiology,atrial fibrillation (AF),TRUE,,
pralatrexate,Launched,dihydrofolate reductase inhibitor,DHFR,hematologic malignancy,peripheral T-cell lymphoma (PTCL),TRUE,,
lomefloxacin,Launched,bacterial DNA gyrase inhibitor,,infectious disease,respiratory tract infections|urinary tract infections,TRUE,,
leucovorin,Launched,folate receptor ligand,,oncology,osteosarcoma,TRUE,,
bafetinib,Phase 2,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,ABL1|BCR|LYN,,,TRUE,,
NSC-23766,Preclinical,Ras GTPase inhibitor,,,,TRUE,,
fenoprofen,Launched,prostaglandin inhibitor,PTGS1|SLC5A8,rheumatology,rheumatoid arthritis|osteoarthritis,TRUE,,
BI-D1870,Preclinical,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6,,,TRUE,,
saxagliptin,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,TRUE,,
meloxicam,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis,TRUE,,
fulvestrant,Launched,estrogen receptor antagonist,ESR1|ESR2|GPER1,oncology,breast cancer,TRUE,,
tetrahydrouridine,Phase 2,cytidine deaminase inhibitor,CDA,,,TRUE,,
tetrahydropapaverine,Preclinical,,,,,TRUE,,
digoxin,Launched,ATPase inhibitor,ATP1A1,cardiology,congestive heart failure|atrial fibrillation (AF),TRUE,,
ketoprofen,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,rheumatology,rheumatoid arthritis|osteoarthritis,TRUE,,
colchicine,Launched,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,rheumatology|endocrinology,gout|fever,TRUE,,
RITA,Preclinical,MDM inhibitor,MDM2,,,TRUE,,
AG-14361,Preclinical,PARP inhibitor,PARP1,,,TRUE,,
famotidine,Launched,histamine receptor antagonist,HRH2,gastroenterology,heartburn,TRUE,,
nitisinone,Launched,hydroxyphenylpyruvate dioxygenase inhibitor,,metabolism,tyrosinemia,TRUE,,
rifampin,Launched,RNA polymerase inhibitor,NR1I2|SLCO1A2|SLCO1B1|SLCO1B3,infectious disease,tuberculosis|meningitis,TRUE,,
dihydromyricetin,Preclinical,,,,,TRUE,,
triapine,Phase 2,ribonucleotide reductase inhibitor,RRM1|RRM2,,,TRUE,,
TAK-901,Phase 1,Aurora kinase inhibitor,AURKB,,,TRUE,,
UNC2250,Preclinical,MER tyrosine kinase inhibitor,MERTK,,,TRUE,,
olaparib,Launched,PARP inhibitor,PARP1|PARP2,oncology,ovarian cancer,TRUE,,
panobinostat,Launched,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,multiple myeloma,TRUE,,
CHIR-124,Preclinical,CHK inhibitor,CHEK1,,,TRUE,,
parbendazole,Preclinical,tubulin polymerization inhibitor,TUBB,,,TRUE,,
sulfanilamide,Launched,carbonic anhydrase inhibitor,CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4,infectious disease,vulvovaginal candidiasis,TRUE,,
PF-477736,Phase 1,CHK inhibitor,CHEK1|CHEK2,,,TRUE,,
NSC-663284,Preclinical,CDC inhibitor,CDC25A|CDC25B|CDC25C,,,TRUE,,
trifluridine,Launched,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,infectious disease,virus herpes simplex (HSV),TRUE,,
NU-6027,Preclinical,CDK inhibitor,CCNA2|CDK2,,,TRUE,,
roquinimex,Phase 3,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,,,TRUE,,
cobimetinib,Launched,MEK inhibitor,MAP2K1,oncology,melanoma,TRUE,,
azacitidine,Launched,DNA methyltransferase inhibitor,DNMT1|DNMT3A,hematologic malignancy|hematology,myelodysplastic diseases (MDS)|anemia|chronic myelomonocytic leukemia (CMMoL),TRUE,,
foretinib,Phase 2,VEGFR inhibitor,FLT1|FLT4|KDR|MET,,,TRUE,,
ixabepilone,Launched,microtubule stabilizing agent,TUBB,oncology,breast cancer,TRUE,,
XL647,Phase 3,EGFR inhibitor|VEGFR inhibitor,EGFR|EPHB4|ERBB2|FLT4|KDR,,,TRUE,,
oxcarbazepine,Launched,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures,TRUE,,
favipiravir,Phase 3,RNA polymerase inhibitor,,,,TRUE,,
drospirenone,Launched,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,endocrinology,contraceptive,TRUE,,
epirubicin,Launched,topoisomerase inhibitor,CHD1|TOP2A,oncology,breast cancer,TRUE,,
YO-01027,Preclinical,gamma secretase inhibitor,,,,TRUE,,
BIBR-1532,Preclinical,telomerase inhibitor,TERT,,,TRUE,,
VE-822,Phase 2,ATR kinase inhibitor,ATM|ATR|MTOR|PIK3CG,,,TRUE,,
GSK1904529A,Preclinical,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,IGF1R|INSR,,,TRUE,,
PD-184352,Phase 2,MEK inhibitor,MAP2K1|MAP3K1|MAP3K2,,,TRUE,,
E7449,Phase 2,PARP inhibitor,PARP1|PARP2|TNKS|TNKS2,,,TRUE,,
dronedarone,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A,cardiology,atrial fibrillation (AF),TRUE,,
posaconazole,Launched,sterol demethylase inhibitor,CYP3A4,infectious disease,oropharyngeal candidiasis,TRUE,,
UK-383367,Phase 1,procollagen C-endopeptidase inhibitor,BMP1,,,TRUE,,
vinblastine,Launched,microtubule inhibitor|tubulin polymerization inhibitor,JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1,hematologic malignancy|infectious disease|oncology,Hodgkin's lymphoma|true histiocytic lymphoma (THL)|mycosis|small lymphocytic lymphoma (SLL)|testicular carcinoma|Kaposi sarcoma,TRUE,,
GSK1838705A,Preclinical,insulin growth factor receptor inhibitor,ALK|IGF1R|INSR|RPS6KA1,,,TRUE,,
cabazitaxel,Launched,microtubule inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,prostate cancer,TRUE,,
BMS-599626,Phase 1,EGFR inhibitor|protein tyrosine kinase inhibitor,EGFR|ERBB2|ERBB4,,,TRUE,,
dexrazoxane,Launched,chelating agent|topoisomerase inhibitor,TOP2A|TOP2B,cardiology,cardiomyopathy,TRUE,,
PF-04691502,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,,,TRUE,,
BAM7,Preclinical,BAX activator,BAX,,,TRUE,,
WHI-P154,Preclinical,JAK inhibitor,EGFR|JAK1|JAK2|JAK3,,,TRUE,,
curcumin,Launched,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,,,TRUE,,
sparfloxacin,Withdrawn,bacterial DNA gyrase inhibitor,TOP2A,,,TRUE,,
VX-702,Phase 2,p38 MAPK inhibitor,IL1B|IL6|MAPK11|MAPK12|MAPK14|TNF,,,TRUE,,
danusertib,Phase 2,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,,,TRUE,,
PF-05212384,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,,,TRUE,,
GSK2126458,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,,,TRUE,,
tetrandrine,Preclinical,calcium channel blocker,SLC6A3,,,TRUE,,
I-BET-762,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,,,TRUE,,
LCL-161,Phase 2,XIAP inhibitor,BIRC2|XIAP,,,TRUE,,
sarafloxacin,Launched,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,TRUE,,
irinotecan,Launched,topoisomerase inhibitor,TOP1|TOP1MT,oncology,colorectal cancer,TRUE,,
ramatroban,Launched,prostanoid receptor antagonist,PTGDR2|TBXA2R,cardiology|pulmonary,coronary artery disease (CAD)|asthma,TRUE,,
pelitinib,Phase 2,EGFR inhibitor,EGFR,,,TRUE,,
D-4476,Preclinical,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,,,TRUE,,
lovastatin,Launched,HMGCR inhibitor,HDAC2|HMGCR|ITGAL|NR1I2,cardiology|endocrinology,coronary heart disease|myocardial infarction|hypercholesterolemia,TRUE,,
PHA-680632,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,,TRUE,,
VS-4718,Phase 1,focal adhesion kinase inhibitor,,,,TRUE,,
dabrafenib,Launched,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,oncology,melanoma,TRUE,,
sulfasalazine,Launched,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,gastroenterology,ulcerative colitis,TRUE,,
temocapril,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology|nephrology,hypertension|congestive heart failure|diabetic nephropathy|coronary artery disease (CAD),TRUE,,
CPI-1189,Phase 2,tumor necrosis factor release inhibitor,TNF,,,TRUE,,
norfloxacin,Launched,bacterial DNA gyrase inhibitor,TOP2A,infectious disease|urology,urinary tract infections|gonorrhea|prostatitis,TRUE,,
tazemetostat,Launched,histone lysine methyltransferase inhibitor,EZH2,,,TRUE,,
aspirin,Launched,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,neurology/psychiatry|endocrinology|dental,headache|fever|toothache|muscle pain,TRUE,,
morin,Preclinical,cytochrome P450 inhibitor,ADORA2A|ESR2|FASN|MCL1|SLC22A12,,,TRUE,,
carmofur,Launched,thymidylate synthase inhibitor,TYMS,oncology,breast cancer|colorectal cancer,TRUE,,
JNJ-7706621,Preclinical,CDK inhibitor,AURKA|AURKB|CDK1|CDK2,,,TRUE,,
pyroxamide,Phase 1,HDAC inhibitor,HDAC1,,,TRUE,,
tipiracil,Launched,thymidine phosphorylase inhibitor,,oncology,colorectal cancer,TRUE,,
LY2608204,Phase 2,glucokinase activator,GCK,,,TRUE,,
vincristine,Launched,tubulin polymerization inhibitor,TUBA4A|TUBB,hematologic malignancy,acute lymphoblastic leukemia (ALL),TRUE,,
trametinib,Launched,MEK inhibitor,MAP2K1|MAP2K2,oncology,melanoma,TRUE,,
fedratinib,Launched,FLT3 inhibitor|JAK inhibitor,BRD4|JAK1|JAK2|JAK3|TYK2,hematologic malignancy,myelofibrosis,TRUE,,
nocodazole,Preclinical,tubulin polymerization inhibitor,HPGDS,,,TRUE,,
CX-5461,Phase 1,RNA polymerase inhibitor,,,,TRUE,,
PCI-24781,Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,,,TRUE,,
ciclopirox,Launched,membrane integrity inhibitor,ATP1A1,infectious disease,onychomycosis,TRUE,,
BMS-754807,Phase 2,IGF-1 inhibitor,AKT1|IGF1R,,,TRUE,,
uridine,Phase 2,dopamine receptor agonist,LSM6|TYMP,,,TRUE,,
PFI-1,Preclinical,bromodomain inhibitor,BRD4,,,TRUE,,
artemisinin,Launched,DNA synthesis inhibitor,CYP2B6,infectious disease,malaria,TRUE,,
AR-42,Phase 1,HDAC inhibitor,HDAC1,,,TRUE,,
pentamidine,Launched,anti-pneumocystis agent,TRDMT1,infectious disease,pneumonia,TRUE,,
piperazine,Launched,benzodiazepine receptor agonist,GABRB3,infectious disease,gastrointestinal roundworms,TRUE,,
AT-7519,Phase 2,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,,,TRUE,,
everolimus,Launched,mTOR inhibitor,MTOR,oncology|neurology/psychiatry|genetics|urology,breast cancer|neuroendocrine tumors of pancreatic origin (PNET)|renal cell carcinoma (RCC)|subependymal giant cell astrocytoma (SEGA)|tuberous sclerosis complex (TSC)|renal angiomyolipoma,TRUE,,
BMS-345541,Preclinical,IKK inhibitor,CHUK|IKBKB,,,TRUE,,
pepstatin,Preclinical,aspartic protease inhibitor,CTSB|CTSD|CTSL|REN,,,TRUE,,
midostaurin,Launched,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,hematologic malignancy,acute myeloid leukemia (AML),TRUE,,
dinaciclib,Phase 3,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,,,TRUE,,
givinostat,Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,,TRUE,,
ritodrine,Withdrawn,adrenergic receptor agonist,,obstetrics/gynecology,premature labor,TRUE,,
LY2603618,Phase 2,CHK inhibitor,CHEK1,,,TRUE,,
MK-0812,Phase 2,CC chemokine receptor antagonist,CCR2,,,TRUE,,
TG-02,Phase 1/Phase 2,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,CDK1|CDK2|CDK7|CDK9|FLT3|JAK2,,,TRUE,,
IKK-16,Preclinical,IKK inhibitor,IKBKB,,,TRUE,,
berberine,Launched,LDL receptor activator,LDLR,,,TRUE,,
GW-501516,Phase 2,PPAR receptor agonist,PPARA|PPARD,,,TRUE,,
GSK650394,Preclinical,serum/glucocorticoid regulated kinase inhibitor,SGK1|SGK2,,,TRUE,,
gemcitabine,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC)|pancreatic cancer,TRUE,,
carfilzomib,Launched,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,hematologic malignancy,multiple myeloma,TRUE,,
papaverine,Launched,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,cardiology|hematology|gastroenterology,myocardial infarction|angina pectoris|pulmonary embolism (PE)|colitis|vascular spasm,TRUE,,
obatoclax,Phase 3,BCL inhibitor,BCL2,,,TRUE,,
cefdinir,Launched,bacterial cell wall synthesis inhibitor,MPO,infectious disease|otolaryngology|pulmonary,pneumonia|tonsillitis|pharyngitis|bronchitis|skin infections|otitis|sinusitis,TRUE,,
clotrimazole,Launched,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,infectious disease,vulvovaginal candidiasis|oropharyngeal candidiasis,TRUE,,
CHIR-99021,Preclinical,glycogen synthase kinase inhibitor,CDK1|GSK3A|GSK3B|MAPK1,,,TRUE,,
oxymetazoline,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,otolaryngology,nasal congestion,TRUE,,
PLX4720,Preclinical,RAF inhibitor,BRAF|KDR,,,TRUE,,
mocetinostat,Phase 2,HDAC inhibitor,HDAC1|HDAC11|HDAC2|HDAC3,,,TRUE,,
evacetrapib,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,,,TRUE,,
regorafenib,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,oncology,colorectal cancer|gastrointestinal stromal tumors (GIST),TRUE,,
filgotinib,Phase 3,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,,,TRUE,,
bendamustine,Launched,DNA inhibitor,,hematologic malignancy,chronic lymphocytic leukemia (CLL)|non-Hodgkin lymphoma (NHL),TRUE,,
chloroxine,Launched,opioid receptor antagonist,OPRK1,gastroenterology|infectious disease|dermatology,diarrhea|inflammatory bowel disease|giardiasis|dandruff,TRUE,,
LY2874455,Phase 1,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,,,TRUE,,
GSK2830371,Preclinical,protein phosphatase inhibitor,PPM1D,,,TRUE,,
talmapimod,Phase 2,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF,,,TRUE,,
indisulam,Phase 2,CDK inhibitor,CA1|CA12|CA14|CA2|CA6|CA7|CA9,,,TRUE,,
PD-168393,Preclinical,EGFR inhibitor,EGFR|ERBB2|SRC,,,TRUE,,
JTC-801,Phase 2,opioid receptor antagonist,OPRL1,,,TRUE,,
belinostat,Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,peripheral T-cell lymphoma (PTCL),TRUE,,
tranilast,Launched,angiogenesis inhibitor,HPGDS|HRH1,pulmonary,asthma,TRUE,,
indirubin,Phase 2/Phase 3,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,,,TRUE,,
HA14-1,Preclinical,BCL inhibitor,BCL2,,,TRUE,,
dalcetrapib,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,,,TRUE,,
estradiol,Launched,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,endocrinology,contraceptive,TRUE,,
LY2801653,Phase 2,MET inhibitor,MET,,,TRUE,,
pacritinib,Phase 3,FLT3 inhibitor|JAK inhibitor,FLT3|JAK1|JAK2|JAK3,,,TRUE,,
mubritinib,Phase 1,protein tyrosine kinase inhibitor,EGFR|ERBB2,,,TRUE,,
gossypol,Phase 2,BCL inhibitor|MCL1 inhibitor,BCL2,,,TRUE,,
RKI-1447,Preclinical,rho associated kinase inhibitor,CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2,,,TRUE,,
SB-242235,Phase 1,p38 MAPK inhibitor,HSPB1|MAPK14,,,TRUE,,
saracatinib,Phase 2/Phase 3,SRC inhibitor,ABL1|LCK|SRC|YES1,,,TRUE,,
lapatinib,Launched,EGFR inhibitor,EGFR|ERBB2,oncology,breast cancer,TRUE,,
eplerenone,Launched,cytochrome P450 inhibitor,NR3C2,cardiology,congestive heart failure|hypertension,TRUE,,
sonidegib,Launched,smoothened receptor antagonist,SMO,oncology,basal cell carcinoma (BCC),TRUE,,
BIX-02188,Preclinical,MEK inhibitor,MAP2K5,,,TRUE,,
LY2606368,Phase 2,CHK inhibitor,CHEK1,,,TRUE,,
bardoxolone,Phase 1,nuclear factor erythroid derived|like (NRF2) activator,NOS2|PPARG,,,TRUE,,
CEP-32496,Phase 1/Phase 2,RAF inhibitor,BRAF|RAF1,,,TRUE,,
SKI-II,Preclinical,sphingosine kinase inhibitor,SPHK1,,,TRUE,,
NVP-TAE226,Preclinical,protein tyrosine kinase inhibitor,PTK2,,,TRUE,,
riluzole,Launched,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,neurology/psychiatry,amyotrophic lateral sclerosis (ALS),TRUE,,
selinexor,Launched,exportin antagonist,XPO1,hematologic malignancy,multiple myeloma,TRUE,,
marimastat,Phase 3,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,,,TRUE,,
desonide,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,gastroenterology,Crohn's disease,TRUE,,
mitoxantrone,Launched,topoisomerase inhibitor,TOP2A,neurology/psychiatry|oncology|hematologic malignancy,multiple sclerosis|prostate cancer|acute myeloid leukemia (AML),TRUE,,
KW-2449,Phase 1,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,,,TRUE,,
AMG900,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,,TRUE,,
AMG458,Preclinical,MET inhibitor,MET,,,TRUE,,
napabucasin,Phase 3,STAT inhibitor,STAT3,,,TRUE,,
crenolanib,Phase 3,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,,,TRUE,,
simvastatin,Launched,HMGCR inhibitor,HMGCR|ITGB2,endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia,TRUE,,
odanacatib,Phase 3,cathepsin inhibitor,CTSK,,,TRUE,,
AV-412,Phase 1,protein tyrosine kinase inhibitor,EGFR|ERBB2,,,TRUE,,
busulfan,Launched,DNA inhibitor,,hematologic malignancy,chronic myeloid leukemia (CML),TRUE,,
GDC-0980,Phase 2,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,,,TRUE,,
CYT-997,Phase 2,tubulin polymerization inhibitor,TUBB,,,TRUE,,
nilutamide,Launched,androgen receptor antagonist,AR,oncology,prostate cancer,TRUE,,
oridonin,Preclinical,BCL inhibitor,BCL2,,,TRUE,,
sorafenib,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,oncology,renal cell carcinoma (RCC)|thyroid cancer|hepatocellular carcinoma (HCC),TRUE,,
AT-9283,Phase 2,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,,,TRUE,,
phlorizin,Preclinical,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A11|SLC5A2|SLC5A3,,,TRUE,,
NVP-AEW541,Preclinical,IGF-1 inhibitor,IGF1R|INSR,,,TRUE,,
5-fluorouracil,Launched,thymidylate synthase inhibitor,DPYD|TYMS,oncology,colorectal cancer|breast cancer|pancreatic cancer|gastric adenocarcinoma,TRUE,,
CNX-2006,Preclinical,EGFR inhibitor,EGFR,,,TRUE,,
apatinib,Phase 3,RET tyrosine kinase inhibitor,CSK|KDR|KIT|RET,,,TRUE,,
OSI-930,Phase 1,KIT inhibitor|VEGFR inhibitor,FLT1|KDR|KIT,,,TRUE,,
GSK2110183,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,,TRUE,,
maprotiline,Launched,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,neurology/psychiatry,depression|dysthymic disorder,TRUE,,
JNJ-16259685,Preclinical,glutamate receptor antagonist,GRM1,,,TRUE,,
LY2784544,Phase 2,JAK inhibitor,JAK2|JAK3,,,TRUE,,
PRT062070,Phase 2/Phase 3,JAK inhibitor|SYK inhibitor,SYK,,,TRUE,,
tucatinib,Phase 3,EGFR inhibitor,ERBB2,,,TRUE,,
NMS-873,Preclinical,ATPase inhibitor,VCP,,,TRUE,,
PD-153035,Phase 1,EGFR inhibitor,EGFR|KDR,,,TRUE,,
imiquimod,Launched,interferon inducer|toll-like receptor agonist,TLR7|TLR8,dermatology|infectious disease|oncology,actinic keratosis (AK)|genital warts|basal cell carcinoma (BCC),TRUE,,
TAK-733,Phase 1,MEK inhibitor,MAP2K1,,,TRUE,,
VX-765,Phase 2,caspase inhibitor,CASP1,,,TRUE,,
VE-821,Preclinical,ATR kinase inhibitor,ATR,,,TRUE,,
BIX-01294,Preclinical,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,,,TRUE,,
costunolide,Preclinical,telomerase inhibitor,,,,TRUE,,
AST-1306,Phase 1,EGFR inhibitor,EGFR|ERBB2,,,TRUE,,
calcitriol,Launched,vitamin D receptor agonist,VDR,endocrinology|orthopedics,hypocalcemia|hypoparathyroidism|osteoporosis,TRUE,,
beta-lapachone,Phase 2,topoisomerase inhibitor,TOP1,,,TRUE,,
cyproheptadine,Launched,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,allergy|otolaryngology|ophthalmology|dermatology,allergic rhinitis|vasomotor rhinitis|conjunctivitis|urticaria|dermatographism,TRUE,,
flutamide,Launched,androgen receptor antagonist,AHR|AR,oncology,prostate cancer,TRUE,,
TW-37,Preclinical,BCL inhibitor,BCL2|BCL2L1|MCL1,,,TRUE,,
AZD4547,Phase 2/Phase 3,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,,,TRUE,,
chidamide,Launched,HDAC inhibitor,HDAC10|HDAC3,hematologic malignancy,peripheral T-cell lymphoma (PTCL),TRUE,,
A-803467,Preclinical,sodium channel blocker,SCN10A,,,TRUE,,
resminostat,Phase 2,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,,,TRUE,,
genipin,Preclinical,choleretic agent,,,,TRUE,,
BGT226,Phase 1/Phase 2,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CG,,,TRUE,,
chlorambucil,Launched,DNA inhibitor,,hematologic malignancy,chronic lymphocytic leukemia (CLL)|Hodgkin's lymphoma,TRUE,,
ziprasidone,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,neurology/psychiatry,schizophrenia|bipolar disorder,TRUE,,
MK-8245,Phase 2,stearoyl-CoA desaturase inhibitor,SCD,,,TRUE,,
axitinib,Launched,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|FLT1|FLT4|KDR|PLK4,oncology,renal cell carcinoma (RCC),TRUE,,
clomifene,Launched,estrogen receptor antagonist,ESR1,obstetrics/gynecology,infertility,TRUE,,
KX2-391,Phase 3,SRC inhibitor|tubulin polymerization inhibitor,SRC,,,TRUE,,
docetaxel,Launched,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,breast cancer|non-small cell lung cancer (NSCLC)|prostate cancer|gastric adenocarcinoma|head and neck squamous cell carcinoma (HNSCC),TRUE,,
unbs-5162,Phase 1,CC chemokine receptor antagonist,,,,TRUE,,
lucitanib,Phase 2,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,,,TRUE,,
AZD9668,Phase 2,elastase inhibitor,ELANE,,,TRUE,,
icotinib,Launched,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC),TRUE,,
temozolomide,Launched,DNA alkylating agent,MGMT,oncology,glioblastoma|astrocytoma,TRUE,,
AMG-208,Phase 1,tyrosine kinase inhibitor,MET,,,TRUE,,
etomoxir,Phase 2,carnitine palmitoyltransferase inhibitor,CPT1A,,,TRUE,,
vanoxerine,Phase 3,dopamine reuptake inhibitor,SLC6A3,,,TRUE,,
disulfiram,Launched,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,neurology/psychiatry,abstinence from alcohol,TRUE,,
azathioprine,Launched,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,transplant|rheumatology,renal homotransplantation|rheumatoid arthritis,TRUE,,
adapalene,Launched,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,dermatology,acne vulgaris (AV),TRUE,,
ouabain,Launched,ATPase inhibitor,ATP1A1,cardiology,hypertension|cardiac arrythmia,TRUE,,
tivantinib,Phase 3,tyrosine kinase inhibitor,MET,,,TRUE,,
exemestane,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer,TRUE,,
rociletinib,Phase 3,EGFR inhibitor,EGFR,,,TRUE,,
abemaciclib,Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer,TRUE,,
clofarabine,Launched,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,hematologic malignancy,acute lymphoblastic leukemia (ALL),TRUE,,
cimetidine,Launched,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,gastroenterology|hematologic malignancy|endocrinology,duodenal ulcer disease|peptic ulcer disease (PUD)|gastroesophageal reflux disease (GERD)|aggressive systemic mastocytosis (ASM)|Zollinger-Ellison syndrome|endocrine adenoma,TRUE,,
streptozotocin,Launched,DNA alkylating agent,,oncology,pancreatic cancer,TRUE,,
levonorgestrel,Launched,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,endocrinology,contraceptive,TRUE,,
methylprednisolone,Launched,glucocorticoid receptor agonist,NR3C1,endocrinology|rheumatology|dermatology|infectious disease|allergy|hematology|neurology/psychiatry|gastroenterology,hypercalcemia|thyroiditis|ankylosing spondylitis|bursitis|osteoarthritis|psoriatic arthritis|seborrheic dermatitis|mycosis|allergic rhinitis|psoriasis|anemia|multiple sclerosis|ulcerative colitis|enteritis,TRUE,,
ciclesonide,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,allergy,allergic rhinitis,TRUE,,
dacarbazine,Launched,DNA alkylating agent,PGD|POLA2,oncology|hematologic malignancy,melanoma|Hodgkin's lymphoma,TRUE,,
gimeracil,Launched,dihydropyrimidine dehydrogenase inhibitor,DPYD,oncology,gastric adenocarcinoma,TRUE,,
niclosamide,Launched,DNA replication inhibitor|STAT inhibitor,STAT3,infectious disease,tapeworm,TRUE,,
ABT-702,Preclinical,adenosine kinase inhibitor,ADK,,,TRUE,,
cycloheximide,Preclinical,protein synthesis inhibitor,RPL3,,,TRUE,,
carmustine,Launched,DNA alkylating agent|DNA inhibitor,GSR,hematologic malignancy|oncology,non-Hodgkin lymphoma (NHL)|Hodgkin's lymphoma|multiple myeloma|glioblastoma|brainstem glioma|medulloblastoma|astrocytoma|ependymoma,TRUE,,
I-BET151,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,,,TRUE,,
dolutegravir,Launched,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,infectious disease,human immunodeficiency virus (HIV-1),TRUE,,
bindarit,Phase 2,NFkB pathway inhibitor,CCL2|CCL7|CCL8,,,TRUE,,
tamibarotene,Launched,retinoid receptor agonist,RARA|RARB,hematologic malignancy,acute promyelocytic leukemia (APL),TRUE,,
GSK1070916,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,,,TRUE,,
ribociclib,Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer,TRUE,,
CEP-33779,Preclinical,JAK inhibitor,JAK2,,,TRUE,,
mifepristone,Launched,glucocorticoid receptor antagonist|progesterone receptor antagonist,AR|NR1I2|NR3C1|PGR,endocrinology,hyperglycemia|diabetes mellitus,TRUE,,
filanesib,Phase 3,kinesin inhibitor|kinesin-like spindle protein inhibitor,KIF11,,,TRUE,,
AZD8330,Phase 1,MEK inhibitor,MAP3K1,,,TRUE,,
SB-525334,Preclinical,TGF beta receptor inhibitor,TGFBR1,,,TRUE,,
dioscin,Preclinical,apoptosis stimulant,CXCR3,,,TRUE,,
PF-03758309,Phase 1,p21 activated kinase inhibitor,PAK4,,,TRUE,,
etoposide,Launched,topoisomerase inhibitor,TOP2A|TOP2B,oncology,non-small cell lung cancer (NSCLC),TRUE,,
bumetanide,Launched,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,cardiology,edema|congestive heart failure,TRUE,,
domperidone,Launched,dopamine receptor antagonist,DRD2|DRD3,infectious disease,fescue toxicosis,TRUE,,
uprosertib,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,,TRUE,,
atiprimod,Phase 2,JAK inhibitor|STAT inhibitor,JAK2|STAT3,,,TRUE,,
ganetespib,Phase 3,HSP inhibitor,HSP90AA1,,,TRUE,,
JK-184,Preclinical,hedgehog pathway inhibitor,,,,TRUE,,
STF-118804,Preclinical,NAMPT inhibitor,NAMPT,,,TRUE,,
triptolide,Phase 3,RNA polymerase inhibitor,RELA,,,TRUE,,
TG-101209,Preclinical,JAK inhibitor,JAK2|JAK3,,,TRUE,,
lenvatinib,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,oncology,thyroid cancer,TRUE,,
bisacodyl,Launched,laxative,,gastroenterology,constipation,TRUE,,
SB-505124,Preclinical,ALK tyrosine kinase receptor inhibitor,TGFBR1,,,TRUE,,
spermidine,Preclinical,glutamate receptor modulator,KCNJ4|TXNRD1,,,TRUE,,
eltrombopag,Launched,thrombopoietin receptor agonist,MPL,hematology|infectious disease,anemia|hepatitis C|thrombocytopenia,TRUE,,
AEE788,Phase 1/Phase 2,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,,,TRUE,,
KW-2478,Phase 1/Phase 2,HSP inhibitor,,,,TRUE,,
CUDC-101,Phase 1,EGFR inhibitor,EGFR|ERBB2,,,TRUE,,
lonafarnib,Phase 3,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,,,TRUE,,
NVP-AUY922,Phase 2,HSP inhibitor,HSP90AA1|HSP90AB1,,,TRUE,,
tioxolone,Preclinical,carbonic anhydrase inhibitor,CA2,,,TRUE,,
buparlisib,Phase 3,PI3K inhibitor,PIK3CA|PIK3CG,,,TRUE,,
verubulin,Phase 2,tubulin polymerization inhibitor,TUBB,,,TRUE,,
osimertinib,Launched,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC),TRUE,,
sunitinib,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,oncology,gastrointestinal stromal tumors (GIST)|renal cell carcinoma (RCC)|neuroendocrine tumors of pancreatic origin (PNET),TRUE,,
temsirolimus,Launched,mTOR inhibitor,MTOR,oncology,renal cell carcinoma (RCC),TRUE,,
GDC-0349,Phase 1,Pim kinase inhibitor,PIK3CA,,,TRUE,,
polydatin,Phase 2,ICAM1 expression inhibitor,ICAM1,,,TRUE,,
daunorubicin,Launched,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,hematologic malignancy,acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL),TRUE,,
BMS-387032,Phase 1,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,CDK2|CDK7|CDK9,,,TRUE,,
OTX015,Phase 1/Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,,,TRUE,,
defactinib,Phase 2,focal adhesion kinase inhibitor,PTK2,,,TRUE,,
CP-673451,Preclinical,PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA|PDGFRB,,,TRUE,,
Y-27632,Preclinical,rho associated kinase inhibitor,PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2,,,TRUE,,
ponatinib,Launched,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK,hematologic malignancy,chronic myeloid leukemia (CML)|acute lymphoblastic leukemia (ALL),TRUE,,
2-methoxyestradiol,Phase 2,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,,,TRUE,,
vismodegib,Launched,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,oncology,basal cell carcinoma (BCC),TRUE,,
taselisib,Phase 3,PI3K inhibitor,PIK3CA,,,TRUE,,
famciclovir,Launched,DNA polymerase inhibitor,,dental|infectious disease,cold sore|genitial herpes|shingles,TRUE,,
clofibrate,Launched,PPAR receptor agonist,LPL|PPARA,endocrinology|cardiology,hyperlipidemia|cholesterol,TRUE,,
7-hydroxystaurosporine,Phase 2,CDK inhibitor|CHK inhibitor|PKC inhibitor,CDK1|CHEK1|CHEK2|GSK3B|LCK|MAPK14|MARK1|MARK3|PDPK1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,,,TRUE,,
JZL-184,Preclinical,monoacylglucerol lipase inhibitor,MGLL,,,TRUE,,
M-344,Preclinical,HDAC inhibitor,HDAC8,,,TRUE,,
MPI-0479605,Preclinical,mitotic kinase inhibitor,TTK,,,TRUE,,
ARRY-334543,Phase 2/Phase 3,EGFR inhibitor,ERBB2,,,TRUE,,
KI-8751,Preclinical,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,,,TRUE,,
LY2109761,Preclinical,TGF beta receptor inhibitor,TGFBR1|TGFBR2,,,TRUE,,
floxuridine,Launched,DNA synthesis inhibitor,TYMS,oncology,colorectal cancer,TRUE,,
podophyllotoxin,Launched,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,infectious disease,genital warts,TRUE,,
cebranopadol,Phase 3,opioid receptor agonist,OPRL1|OPRM1,,,TRUE,,
CNX-774,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,,TRUE,,
methyldopa,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,cardiology,hypertension,TRUE,,
nintedanib,Launched,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,pulmonary,idiopathic pulmonary fibrosis (IPF),TRUE,,
prazosin,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,cardiology,hypertension,TRUE,,
dasatinib,Launched,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,hematologic malignancy,chronic myeloid leukemia (CML)|acute lymphoblastic leukemia (ALL),TRUE,,
thioguanine,Launched,purine antagonist,IMPDH1|IMPDH2,hematologic malignancy,acute myeloid leukemia (AML),TRUE,,
PIK-75,Preclinical,DNA protein kinase inhibitor|PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,,,TRUE,,
pilaralisib,Phase 2,PI3K inhibitor,,,,TRUE,,
BMS-707035,Phase 2,HIV integrase inhibitor,,,,TRUE,,
BX-912,Preclinical,pyruvate dehydrogenase kinase inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,,,TRUE,,
PD-0325901,Phase 2,MEK inhibitor,MAP2K1,,,TRUE,,
mesna,Launched,antioxidant,,urology,hemorrhagic cystitis,TRUE,,
baicalin,Launched,beta glucuronidase inhibitor,PREP,neurology/psychiatry,anxiety,TRUE,,
PHA-767491,Preclinical,CDC inhibitor,CDK1|RPS6KB1,,,TRUE,,
abiraterone,Launched,androgen biosynthesis inhibitor,CYP11B1|CYP17A1,oncology,prostate cancer,TRUE,,
NVP-TAE684,Preclinical,ALK tyrosine kinase receptor inhibitor,ALK|INSR,,,TRUE,,
canertinib,Phase 3,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,,,TRUE,,
fenofibrate,Launched,PPAR receptor agonist,MMP25|PPARA,endocrinology,hypercholesterolemia|hypertriglyceridemia,TRUE,,
capsaicin,Launched,TRPV agonist,CFTR|TRPV1,neurology/psychiatry|rheumatology,muscle pain|rheumatoid arthritis,TRUE,,
dienogest,Launched,progesterone receptor agonist,PGR,endocrinology|obstetrics/gynecology,contraceptive|endometriosis,TRUE,,
tropisetron,Launched,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,gastroenterology,nausea|vomiting,TRUE,,
palbociclib,Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer,TRUE,,
fenbendazole,Launched,tubulin polymerization inhibitor,TUBB,infectious disease,gastrointestinal parasites|gastrointestinal roundworms,TRUE,,
toremifene,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,oncology,breast cancer,TRUE,,
taurine,Launched,antioxidant,,neurology/psychiatry,anxiety|irritability|sleeplessness,TRUE,,
cabozantinib,Launched,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,oncology,medullary thyroid cancer (MTC),TRUE,,
TPCA-1,Preclinical,IKK inhibitor,IKBKB,,,TRUE,,
ilomastat,Phase 3,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,,,TRUE,,
hydroxyurea,Launched,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,hematologic malignancy|oncology,chronic myeloid leukemia (CML)|head and neck squamous cell carcinoma (HNSCC),TRUE,,
nemorubicin,Phase 2,topoisomerase inhibitor,TOP1|TOP2A,,,TRUE,,
BIIB021,Phase 2,HSP inhibitor,HSP90AA1,,,TRUE,,
metronidazole,Launched,DNA inhibitor,CYP2C9|CYP3A4,dermatology,rosacea,TRUE,,
oxibendazole,Launched,tubulin polymerization inhibitor,TUBB|TUBB4B,infectious disease,strongyles,TRUE,,
anastrozole,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer,TRUE,,
R547,Phase 1,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,,,TRUE,,
chlorhexidine,Launched,membrane integrity inhibitor,,dermatology|infectious disease|dental,cosmetic|skin infections|gingivitis,TRUE,,
tacedinaline,Phase 3,HDAC inhibitor,HDAC1,,,TRUE,,
TAK-715,Phase 2,p38 MAPK inhibitor,MAPK14,,,TRUE,,
GDC-0941,Phase 2,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,,TRUE,,
tivozanib,Launched,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,oncology,renal cell carcinoma (RCC),TRUE,,
baricitinib,Launched,JAK inhibitor,JAK1|JAK2,rheumatology,rheumatoid arthritis,TRUE,,
MK-5108,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,,TRUE,,
ruxolitinib,Launched,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,hematologic malignancy|hematology,myelofibrosis|polycythemia vera,TRUE,,
MK-1775,Phase 2,WEE1 kinase inhibitor,WEE1,,,TRUE,,
monobenzone,Launched,melanin inhibitor,TYR,dermatology,skin depigmentation,TRUE,,
zolmitriptan,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,neurology/psychiatry,migraine headache,TRUE,,
artesunate,Launched,DNA synthesis inhibitor,,infectious disease,malaria,TRUE,,
niraparib,Launched,PARP inhibitor,PARP1,oncology,primary peritoneal cancer (PPC),TRUE,,
alpelisib,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,oncology,breast cancer,TRUE,,
amoxicillin,Launched,penicillin binding protein inhibitor,CYP2C19|SLC15A1|SLC15A2|SLC22A6,infectious disease|gastroenterology,skin infections|duodenal ulcer disease|gonorrhea|ear infections|throat infections|genitourinary tract infections|respiratory tract infections,TRUE,,
rigosertib,Phase 3,cell cycle inhibitor|PLK inhibitor,PLK1,,,TRUE,,
torcetrapib,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,,,TRUE,,
topotecan,Launched,topoisomerase inhibitor,TOP1|TOP1MT,oncology,small cell lung cancer|cervical cancer,TRUE,,
latrepirdine,Phase 3,glutamate receptor antagonist,HRH1|HTR6,,,TRUE,,
orantinib,Phase 3,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,,,TRUE,,
AP26113,Phase 2,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,,,TRUE,,
MGCD-265,Preclinical,VEGFR inhibitor,AXL|MET,,,TRUE,,
voxtalisib,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,,,TRUE,,
ABT-737,Phase 1/Phase 2,BCL inhibitor,BCL2|BCL2L1|BCL2L2,,,TRUE,,
amonafide,Phase 3,topoisomerase inhibitor,TOP2A|TOP2B,,,TRUE,,
vemurafenib,Launched,RAF inhibitor,BRAF|RAF1,oncology,melanoma,TRUE,,
MK-2461,Phase 1/Phase 2,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,,,TRUE,,
Y-39983,Phase 2,rho associated kinase inhibitor,ROCK1|ROCK2,,,TRUE,,
enzalutamide,Launched,androgen receptor antagonist,AR,oncology,prostate cancer,TRUE,,
dacinostat,Phase 1,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,,TRUE,,
selumetinib,Phase 3,MEK inhibitor,MAP2K1,,,TRUE,,
dacomitinib,Launched,EGFR inhibitor,EGFR|ERBB2|ERBB4,,,TRUE,,
hesperadin,Preclinical,Aurora kinase inhibitor,AURKB,,,TRUE,,
doxifluridine,Launched,thymidylate synthase inhibitor,TYMS,oncology,colorectal cancer,TRUE,,
AT13387,Phase 2,HSP inhibitor,HSP90AA1,,,TRUE,,
ONC201,Phase 2,AKT inhibitor|MAP kinase inhibitor,TNFSF10,,,TRUE,,
FK-866,Phase 2,niacinamide phosphoribosyltransferase inhibitor,NAMPT,,,TRUE,,
acetylcysteine,Launched,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,gastroenterology,acetaminophen overdose|hepatic injury,TRUE,,
naproxen,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry|rheumatology|dental|otolaryngology|endocrinology,pain relief|rheumatoid arthritis|headache|toothache|backache|muscle pain|common cold|fever,TRUE,,
delanzomib,Phase 1/Phase 2,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,,,TRUE,,
piperine,Phase 1,monoamine oxidase inhibitor,MAOA|MAOB|TRPV1,,,TRUE,,
ubenimex,Launched,leukotriene synthesis inhibitor,LTA4H|RNPEP,hematologic malignancy,acute myeloid leukemia (AML),TRUE,,
quinidine,Launched,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,infectious disease|cardiology,malaria|atrial fibrillation (AF)|ventricular arrhythmias,TRUE,,
vindesine,Launched,tubulin polymerization inhibitor,TUBB|TUBB1,oncology,breast cancer|non-small cell lung cancer (NSCLC)|melanoma,TRUE,,
LDN-212854,Preclinical,bone morphogenic protein inhibitor,ABL1|ACVR1|RIPK2,,,TRUE,,
tiagabine,Launched,GABA uptake inhibitor,SLC6A1,neurology/psychiatry,seizures,TRUE,,
MG-132,Preclinical,proteasome inhibitor,PSMB1,,,TRUE,,
niacin,Launched,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,endocrinology,hypertriglyceridemia,TRUE,,
ribavirin,Launched,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,infectious disease,hepatitis C,TRUE,,
ONX-0914,Preclinical,proteasome inhibitor,,,,TRUE,,
paricalcitol,Launched,vitamin D receptor agonist,VDR,nephrology|endocrinology,chronic kidney disease (CKD)|hyperthyroidism,TRUE,,
idelalisib,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,hematologic malignancy,chronic lymphocytic leukemia (CLL),TRUE,,
PHA-848125,Phase 2,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,,,TRUE,,
capecitabine,Launched,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,oncology,breast cancer|colorectal cancer,TRUE,,
romidepsin,Launched,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,cutaneous T-cell lymphoma (CTCL),TRUE,,
resatorvid,Phase 3,toll-like receptor inhibitor,TLR4,,,TRUE,,
fleroxacin,Launched,topoisomerase inhibitor,TOP2A,infectious disease|gastroenterology,gonorrhea|enteritis|diarrhea|respiratory tract infections,TRUE,,
AS-1949490,Preclinical,SHIP2 phosphatase inhibitor,INPP5D,,,TRUE,,
paclitaxel,Launched,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC),TRUE,,
AVN-944,Phase 2,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,,,TRUE,,
anagrelide,Launched,phosphodiesterase inhibitor,PDE3A,hematology|hematologic malignancy,thrombocythemia|myeloproliferative neoplasms,TRUE,,
deforolimus,Phase 3,mTOR inhibitor,MTOR,,,TRUE,,
venetoclax,Launched,BCL inhibitor,BCL2,hematologic malignancy,chronic lymphocytic leukemia (CLL),TRUE,,
aztreonam,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|respiratory tract infections|bacterial septicemia|skin infections|intra-abdominal infections|gynecologic infections,TRUE,,
idasanutlin,Phase 3,MDM inhibitor,MDM2|TP53,,,TRUE,,
PD-98059,Preclinical,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,,,TRUE,,
BMS-265246,Preclinical,CDK inhibitor,CDK1|CDK2,,,TRUE,,
tipifarnib,Phase 3,farnesyltransferase inhibitor,FNTA|FNTB,,,TRUE,,
ZSTK-474,Phase 1/Phase 2,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,,,TRUE,,
epinephrine,Launched,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,cardiology|allergy|pulmonary,cardiac arrest|anaphylactic shock|asthma,TRUE,,
semaxanib,Phase 3,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,,,TRUE,,
acipimox,Launched,cholesterol inhibitor,HCAR2,endocrinology,hyperlipidemia,TRUE,,
10-hydroxycamptothecin,Preclinical,topoisomerase inhibitor,TOP1,,,TRUE,,
raloxifene,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,orthopedics|oncology,osteoporosis|breast cancer,TRUE,,
gefitinib,Launched,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC),TRUE,,
vinflunine,Launched,microtubule inhibitor,,oncology,bladder cancer,TRUE,,
Ro-4987655,Phase 1,MEK inhibitor,MAP2K1,,,TRUE,,
TG100-115,Phase 1/Phase 2,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,,TRUE,,
PHA-793887,Phase 1,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,,,TRUE,,
CYC116,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|KDR,,,TRUE,,
ispinesib,Phase 2,kinesin inhibitor,KIF11,,,TRUE,,
BI-2536,Phase 2,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,,,TRUE,,
AMG-232,Phase 2,MDM inhibitor,MDM2,,,TRUE,,
nefiracetam,Phase 3,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,,,TRUE,,
serdemetan,Phase 1,MDM inhibitor,MDM2,,,TRUE,,
AZD1480,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,,,TRUE,,
salidroside,Preclinical,beta amyloid protein neurotoxicity inhibitor,APP,,,TRUE,,
fluvastatin,Launched,HMGCR inhibitor,HMGCR,endocrinology|cardiology,hypercholesterolemia|congenital heart defects,TRUE,,
fludarabine,Launched,ribonucleotide reductase inhibitor,ADA|DCK|POLA1|RRM1|RRM2,hematologic malignancy,chronic lymphocytic leukemia (CLL),TRUE,,
MK-3207,Phase 2,calcitonin antagonist,CALCA,,,TRUE,,
altretamine,Launched,DNA synthesis inhibitor,,oncology,ovarian cancer,TRUE,,
SB-431542,Preclinical,TGF beta receptor inhibitor,ACVR1C|TGFBR1,,,TRUE,,
cyclocytidine,Preclinical,DNA synthesis inhibitor|RNA synthesis inhibitor,,,,TRUE,,
KU-0063794,Preclinical,mTOR inhibitor,MTOR,,,TRUE,,
GDC-0879,Preclinical,RAF inhibitor,BRAF,,,TRUE,,
pevonedistat,Phase 3,nedd activating enzyme inhibitor,NAE1|UBA3,,,TRUE,,
PI-103,Preclinical,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,,,TRUE,,
eprosartan,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension,TRUE,,
MK-2206,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,,TRUE,,
torin-2,Preclinical,mTOR inhibitor,MTOR,,,TRUE,,
amsacrine,Launched,topoisomerase inhibitor,KCNH2|TOP2A,hematologic malignancy,acute lymphoblastic leukemia (ALL),TRUE,,
carboxyamidotriazole,Phase 3,calcium channel blocker,CXCL8,,,TRUE,,
ENMD-2076,Phase 2,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,,,TRUE,,
SB-743921,Phase 1/Phase 2,kinesin-like spindle protein inhibitor,KIF11,,,TRUE,,
PF-03814735,Phase 1,Aurora kinase inhibitor,AURKA|AURKB,,,TRUE,,
flumatinib,Phase 3,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,,,TRUE,,
cephalomannine,Preclinical,DNA polymerase inhibitor,,,,TRUE,,
GDC-0152,Phase 1,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,,,TRUE,,
PF-3845,Preclinical,FAAH inhibitor,FAAH,,,TRUE,,
golvatinib,Phase 2,VEGFR inhibitor,KDR|MET,,,TRUE,,
cisplatin,Launched,DNA alkylating agent|DNA synthesis inhibitor,XIAP,oncology,testicular carcinoma|ovarian cancer|bladder cancer,TRUE,,
vinorelbine,Launched,tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,non-small cell lung cancer (NSCLC),TRUE,,
tacrolimus,Launched,calcineurin inhibitor,FKBP1A,transplant,organ rejection,TRUE,,
idarubicin,Launched,topoisomerase inhibitor,TOP2A,hematologic malignancy,acute myeloid leukemia (AML),TRUE,,
atorvastatin,Launched,HMGCR inhibitor,AHR|DPP4|HMGCR,neurology/psychiatry|cardiology,stroke|heart attack,TRUE,,
volasertib,Phase 3,PLK inhibitor,PLK1,,,TRUE,,
AZD8055,Phase 1,mTOR inhibitor,MTOR,,,TRUE,,
SMI-4a,Preclinical,Pim kinase inhibitor,PIM1,,,TRUE,,
vatalanib,Phase 3,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR|PDGFRB,,,TRUE,,
riboflavin,Launched,vitamin B,BLVRB|RFK,gastroenterology,jaundice,TRUE,,
ibrutinib,Launched,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,hematologic malignancy,chronic lymphocytic leukemia (CLL)|mantle cell lymphoma (MCL)|Waldenstrom's macroglobulinemia (WM),TRUE,,
aripiprazole,Launched,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,neurology/psychiatry,depression|schizophrenia|bipolar disorder,TRUE,,
erlotinib,Launched,EGFR inhibitor,EGFR|NR1I2,oncology,non-small cell lung cancer (NSCLC)|pancreatic cancer,TRUE,,
ranitidine,Launched,histamine receptor antagonist,HRH2,gastroenterology,heartburn,TRUE,,
HMN-214,Phase 1,PLK inhibitor,PLK1,,,TRUE,,
masitinib,Launched,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,dermatology,mastocytoma,TRUE,,
dorzolamide,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,ophthalmology,intraocular pressure|glaucoma,TRUE,,
birinapant,Phase 2,XIAP inhibitor,BIRC2|XIAP,,,TRUE,,
SNX-2112,Phase 1,HSP inhibitor,,,,TRUE,,
KPT-185,Preclinical,exportin antagonist,XPO1,,,TRUE,,
GDC-0068,Phase 3,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,,,TRUE,,
SNS-314,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,,TRUE,,
vidarabine,Launched,antiviral,ADA,infectious disease,virus herpes simplex (HSV)|varicella-zoster virus (VZV),TRUE,,
TAME,Preclinical,,,,,TRUE,,
gilteritinib,Launched,FLT3 inhibitor,FLT3,,,TRUE,,
baicalein,Preclinical,lipoxygenase inhibitor,ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH,,,TRUE,,
WZ-4002,Preclinical,EGFR inhibitor,EGFR|ERBB2,,,TRUE,,
ZM-447439,Preclinical,Aurora kinase inhibitor,AURKA|AURKB,,,TRUE,,
CEP-37440,Phase 1,ALK tyrosine kinase receptor inhibitor,ALK,,,TRUE,,
valrubicin,Launched,DNA inhibitor|topoisomerase inhibitor,TOP2A,oncology,bladder cancer,TRUE,,
SNX-5422,Phase 1/Phase 2,HSP inhibitor,HSP90AA1|HSP90AB1,,,TRUE,,
WZ-3146,Preclinical,EGFR inhibitor,EGFR,,,TRUE,,
OSI-420,Preclinical,EGFR inhibitor,EGFR,,,TRUE,,
PF-04217903,Phase 1,c-Met inhibitor,MET,,,TRUE,,
cinacalcet,Launched,calcium channel activator,CASR,endocrinology|nephrology|oncology,hyperparathyroidism|chronic kidney disease (CKD)|parathyroid carcinoma|hypercalcemia,TRUE,,
BI-78D3,Preclinical,JNK inhibitor,MAPK8,,,TRUE,,
indibulin,Phase 1/Phase 2,tubulin polymerization inhibitor,,,,TRUE,,
azithromycin,Launched,bacterial 50S ribosomal subunit inhibitor,MLNR,infectious disease,pelvic inflammatory disease|pneumonia,TRUE,,
pazopanib,Launched,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,oncology,renal cell carcinoma (RCC)|soft tissue sarcoma (STS),TRUE,,
idronoxil,Phase 3,XIAP inhibitor,ENOX2|SPHK1,,,TRUE,,
SCH-900776,Phase 2,CHK inhibitor,CDK2|CHEK1,,,TRUE,,
alisertib,Phase 3,Aurora kinase inhibitor,AURKA,,,TRUE,,
KPT-276,Preclinical,exportin antagonist,XPO1,,,TRUE,,
tioguanine,Launched,purine antagonist,,hematologic malignancy,acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL)|chronic myeloid leukemia (CML),TRUE,,
pitavastatin,Launched,HMGCR inhibitor,HMGCR,endocrinology,hyperlipidemia,TRUE,,
resiquimod,Phase 3,toll-like receptor agonist,TLR7|TLR8,,,TRUE,,
BMS-690514,Phase 2,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|FLT3|KDR,,,TRUE,,
CCT128930,Preclinical,AKT inhibitor,,,,TRUE,,
idoxuridine,Launched,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,infectious disease,virus herpes simplex (HSV),TRUE,,
homoharringtonine,Launched,protein synthesis inhibitor,RPL3,hematologic malignancy,chronic myeloid leukemia (CML),TRUE,,
YM-155,Phase 2,survivin inhibitor,BIRC5,,,TRUE,,
WYE-354,Preclinical,mTOR inhibitor,MTOR,,,TRUE,,
triamcinolone,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,TRUE,,
vandetanib,Launched,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,oncology,medullary thyroid cancer (MTC),TRUE,,
CUDC-907,Phase 2,PI3K inhibitor,HDAC2|PIK3R1,,,TRUE,,
entinostat,Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,,,TRUE,,
mebendazole,Launched,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,infectious disease,pinworm|whipworm|hookworm|ascariasis,TRUE,,
LY2090314,Phase 2,glycogen synthase kinase inhibitor,GSK3B,,,TRUE,,
GW-788388,Preclinical,ALK tyrosine kinase receptor inhibitor,LCK|MAPK14|TGFBR1,,,TRUE,,
menadione,Launched,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,gastroenterology|neurology/psychiatry|dermatology|rheumatology,ulcerative colitis|diarrhea|headache|varicose veins|rheumatoid arthritis,TRUE,,
A-674563,Preclinical,AKT inhibitor,AKT1|PKIA|PRKACA,,,TRUE,,
crizotinib,Launched,ALK tyrosine kinase receptor inhibitor,ALK|MET,oncology,non-small cell lung cancer (NSCLC),TRUE,,
ixazomib,Launched,proteasome inhibitor,,hematologic malignancy,multiple myeloma,TRUE,,
pentagastrin,Launched,CCK receptor agonist,CCKBR,gastroenterology,anacidity diagnostic|gastric hypersecretion diagnostic,TRUE,,
oxaliplatin,Launched,DNA inhibitor,,oncology,colorectal cancer,TRUE,,
albendazole,Launched,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,infectious disease,cystic hydatid disease|parenchymal neurocysticercosis,TRUE,,
nimorazole,Launched,bacterial DNA inhibitor,,oncology,head and neck squamous cell carcinoma (HNSCC),TRUE,,
PF-573228,Preclinical,focal adhesion kinase inhibitor,CDK1|CDK2|CDK7|GSK3B|IKBKB,,,TRUE,,
decitabine,Launched,DNA methyltransferase inhibitor,DNMT1|DNMT3A,hematologic malignancy|hematology,myelodysplastic diseases (MDS)|anemia|chronic myeloid leukemia (CML),TRUE,,
NVP-BHG712,Preclinical,ephrin inhibitor,EPHB4,,,TRUE,,
CGM097,Phase 1,MDM inhibitor,MDM2,,,TRUE,,
uracil,Launched,,DPYD|UCKL1,,,TRUE,,
TAK-285,Phase 1,EGFR inhibitor,ERBB2,,,TRUE,,
triciribine,Phase 1/Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,,TRUE,,
repsox,Preclinical,TGF beta receptor inhibitor,TGFBR1,,,TRUE,,
erteberel,Phase 2,estrogen receptor agonist,ESR1|ESR2,,,TRUE,,
SGI-1776,Phase 1,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,,,TRUE,,
tideglusib,Phase 2,glycogen synthase kinase inhibitor,GSK3B,,,TRUE,,
vorinostat,Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9,hematologic malignancy,cutaneous T-cell lymphoma (CTCL),TRUE,,
CX-4945,Phase 1/Phase 2,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,,,TRUE,,
tanespimycin,Phase 3,HSP inhibitor,HSP90AA1,,,TRUE,,
nilotinib,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,hematologic malignancy,chronic myeloid leukemia (CML),TRUE,,
PP-121,Preclinical,protein tyrosine kinase inhibitor,ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC,,,TRUE,,
estrone,Launched,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,endocrinology,menopause,TRUE,,
SB-239063,Preclinical,p38 MAPK inhibitor,MAPK11|MAPK14|PTGS2,,,TRUE,,
elesclomol,Phase 3,oxidative stress inducer,HSPA1A,,,TRUE,,
binimetinib,Launched,MEK inhibitor,MAP2K1|MAP2K2,oncology,melanoma,TRUE,,
navitoclax,Phase 2,BCL inhibitor,BCL2|BCL2L1|BCL2L2,,,TRUE,,
batimastat,Phase 3,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,,,TRUE,,
repaglinide,Launched,insulin secretagogue,ABCC8|KCNJ11|PPARG,endocrinology,diabetes mellitus,TRUE,,
daclatasvir,Launched,HCV inhibitor,,infectious disease,hepatitis C,TRUE,,
ACY-1215,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,,,TRUE,,
doxercalciferol,Launched,vitamin D receptor agonist,VDR,nephrology|endocrinology,chronic kidney disease (CKD)|hyperparathyroidism,TRUE,,
LY3023414,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR,,,TRUE,,
litronesib,Phase 2,kinesin-like spindle protein inhibitor,KIF11,,,TRUE,,
chloropyramine,Launched,histamine receptor antagonist,HRH1,cardiology|ophthalmology|allergy|pulmonary,edema|conjunctivitis|allergic rhinitis|asthma,TRUE,,
NMS-1286937,Phase 2,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,,,TRUE,,
JNJ-26481585,Phase 2,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,,,TRUE,,
MLN8054,Phase 1,Aurora kinase inhibitor,AURKA,,,TRUE,,
alvespimycin,Phase 2,HSP inhibitor,HSP90AA1,,,TRUE,,
nelarabine,Launched,DNA synthesis inhibitor|T cell inhibitor,POLA1,hematologic malignancy,acute lymphoblastic leukemia (ALL),TRUE,,
telatinib,Phase 2,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,,,TRUE,,
riociguat,Launched,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,cardiology,hypertension,TRUE,,
erdafitinib,Launched,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4,,,TRUE,,
sirolimus,Launched,mTOR inhibitor,FKBP1A|MTOR,transplant|pulmonary,organ rejection|lymphangioleiomyomatosis,TRUE,,
AZD2461,Phase 1,PARP inhibitor,,,,TRUE,,
novobiocin,Launched,bacterial DNA gyrase inhibitor,,obstetrics/gynecology,mastitis,TRUE,,
dovitinib,Phase 3,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB,,,TRUE,,
ivermectin,Launched,benzodiazepine receptor agonist,CHRNA7|P2RX7,infectious disease,gastrointestinal roundworms|lungworms|cattle grubs|mites|lice|horn flies,TRUE,,
neratinib,Launched,EGFR inhibitor,EGFR|ERBB2|KDR,oncology,breast cancer,TRUE,,
refametinib,Phase 2,MEK inhibitor,MAP2K1|MAP2K2,,,TRUE,,
AZD2858,Preclinical,glycogen synthase kinase inhibitor,GSK3B,,,TRUE,,
WAY-600,Preclinical,mTOR inhibitor,MTOR,,,TRUE,,
flubendazole,Launched,tubulin polymerization inhibitor,TUBB,infectious disease,gastrointestinal parasites,TRUE,,
linsitinib,Phase 3,IGF-1 inhibitor,IGF1R|INSR|INSRR,,,TRUE,,
AZD7762,Phase 1,CHK inhibitor,CHEK1|CHEK2,,,TRUE,,
embelin,Preclinical,HCV inhibitor|XIAP inhibitor,XIAP,,,TRUE,,
SB-939,Phase 3,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9,,,TRUE,,
PF-04457845,Phase 2,FAAH inhibitor,FAAH,,,TRUE,,
dofetilide,Withdrawn,potassium channel blocker,KCNH1|KCNH2|KCNJ12|KCNK2,,,TRUE,,
cediranib,Phase 3,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,,,TRUE,,
oltipraz,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,ANG,,,TRUE,,
phenelzine,Launched,monoamine oxidase inhibitor,ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression,TRUE,,
PP242,Preclinical,mTOR inhibitor,MTOR|PASK,,,TRUE,,
OSI-027,Phase 1,mTOR inhibitor,MTOR,,,TRUE,,
norepinephrine,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2,cardiology|allergy|neurology/psychiatry,hypertension|urticaria|headache|seasonal affective disorder,TRUE,,
cyt387,Phase 3,JAK inhibitor,JAK1|JAK2|JAK3,,,TRUE,,
istradefylline,Launched,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,neurology/psychiatry,Parkinson's Disease|dyskinesia,TRUE,,
AVL-292,Phase 2,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,,,TRUE,,
melphalan,Launched,DNA alkylating agent|DNA inhibitor,,hematologic malignancy,multiple myeloma,TRUE,,
alvocidib,Phase 2,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,,,TRUE,,
naltrexone,Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1|SIGMAR1,neurology/psychiatry,abstinence from alcohol,TRUE,,
pyrimethamine,Launched,dihydrofolate reductase inhibitor,DHFR|SLC47A1,infectious disease,malaria,TRUE,,
bortezomib,Launched,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,hematologic malignancy,multiple myeloma|mantle cell lymphoma (MCL),TRUE,,
PD-198306,Preclinical,MAP kinase inhibitor|MEK inhibitor,MAP2K1|MAP2K2,,,TRUE,,
letrozole,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer,TRUE,,
elacridar,Phase 1,P glycoprotein inhibitor,ABCB1,,,TRUE,,
AS-703026,Phase 2,MEK inhibitor,MAP2K1|MAP2K2,,,TRUE,,
GSK923295,Phase 1,centromere associated protein inhibitor,CENPE,,,TRUE,,
fenretinide,Phase 3,apoptosis stimulant|retinoid receptor agonist,RARA,,,TRUE,,
tandutinib,Phase 2,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,,,TRUE,,
raltitrexed,Launched,thymidylate synthase inhibitor,FPGS|TYMS,oncology,mesothelioma,TRUE,,
GW-843682X,Preclinical,PLK inhibitor,PLK1|PLK3,,,TRUE,,
AR-12,Phase 1,phosphoinositide dependent kinase inhibitor,PDPK1,,,TRUE,,
carboplatin,Launched,DNA alkylating agent|DNA inhibitor,,oncology,ovarian cancer,TRUE,,
indiplon,Phase 3,benzodiazepine receptor agonist,GABRA1,,,TRUE,,
pentostatin,Launched,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA,hematologic malignancy,hairy cell leukemia,TRUE,,
mercaptopurine,Launched,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,hematologic malignancy,acute lymphoblastic leukemia (ALL),TRUE,,
ABT-751,Phase 2,tubulin polymerization inhibitor,TUBB,,,TRUE,,
doxorubicin,Launched,topoisomerase inhibitor,TOP2A,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma,TRUE,,
tosedostat,Phase 2,peptidase inhibitor,ANPEP|LAP3|NPEPPS,,,TRUE,,
GSK461364,Phase 1,PLK inhibitor,PLK1,,,TRUE,,
bexarotene,Launched,retinoid receptor agonist,RXRA|RXRB|RXRG,hematologic malignancy,cutaneous T-cell lymphoma (CTCL),TRUE,,
tirapazamine,Phase 3,DNA inhibitor,,,,TRUE,,
PAC-1,Phase 1,caspase activator,CASP3,,,TRUE,,
cladribine,Launched,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,hematologic malignancy,hairy cell leukemia,TRUE,,
RAF265,Phase 2,RAF inhibitor|VEGFR inhibitor,BRAF,,,TRUE,,
hydrocortisone,Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,dermatology|neurology/psychiatry,eczema|psoriasis|seborrheic dermatitis|itching,TRUE,,
tamoxifen,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,oncology,breast cancer,TRUE,,
taltirelin,Launched,thyrotropin releasing hormone receptor agonist,TRHR,neurology/psychiatry,spinocerebellar ataxia,TRUE,,
quizartinib,Phase 3,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,,,TRUE,,
TWS-119,Preclinical,glycogen synthase kinase inhibitor,GSK3B|JUN|MYC,,,TRUE,,
mevastatin,Preclinical,HMGCR inhibitor,HMGCR,,,TRUE,,
ICG-001,Preclinical,beta-catenin inhibitor,CTNNB1,,,TRUE,,
LDN-57444,Preclinical,ubiquitin C-terminal hydrolase inhibitor,,,,TRUE,,
talazoparib,Launched,PARP inhibitor,PARP2,oncology,breast cancer,TRUE,,
PHA-665752,Preclinical,c-Met inhibitor,MET,,,TRUE,,
SRT1720,Preclinical,SIRT activator,SIRT1,,,TRUE,,
deflazacort,Launched,glucocorticoid receptor agonist,NR3C1,rheumatology,joint inflammation,TRUE,,
azalomycin-B,Preclinical,bacterial 50S ribosomal subunit inhibitor,,,,TRUE,,
brequinar,Phase 2,dihydroorotate dehydrogenase inhibitor,DHODH,,,TRUE,,
cidofovir,Launched,DNA polymerase inhibitor,,infectious disease,acquired immunodeficiency syndrome (AIDS)|cytomegalovirus retinitis,TRUE,,
Y-320,Preclinical,interleukin inhibitor,IL17A,,,TRUE,,
10-deacetylbaccatin,Preclinical,antitumor agent,,,,TRUE,,
deferasirox,Launched,chelating agent,CYP3A4,hematology,transfusional hemosiderosis|thalassemia|iron overload,TRUE,,
nicorandil,Launched,nitric oxide donor|potassium channel activator,KCNJ11,cardiology,angina pectoris,TRUE,,
GSK-J4,Preclinical,histone lysine demethylase inhibitor,KDM6A|KDM6B,,,TRUE,,
parthenolide,Phase 1,NFkB pathway inhibitor,,,,TRUE,,
AZD5363,Phase 3,AKT inhibitor,AKT1|AKT2|AKT3,,,TRUE,,
felbamate,Launched,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,neurology/psychiatry,epilepsy,TRUE,,
AZD2014,Phase 2,mTOR inhibitor,MTOR,,,TRUE,,
NSC-319726,Preclinical,p53 activator,,,,TRUE,,
ftorafur,Launched,thymidylate synthase inhibitor,TYMS,oncology,colorectal cancer,TRUE,,
genz-644282,Phase 1,topoisomerase inhibitor,TOP1,,,TRUE,,
plinabulin,Phase 3,tubulin polymerization inhibitor,,,,TRUE,,
PF-562271,Phase 1,focal adhesion kinase inhibitor,PTK2|PTK2B,,,TRUE,,
motesanib,Phase 3,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR|KIT,,,TRUE,,
linifanib,Phase 3,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,,,TRUE,,
lorlatinib,Launched,ALK tyrosine kinase receptor inhibitor,ALK,oncology,non-small cell lung cancer (NSCLC),TRUE,,
bosutinib,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,hematologic malignancy,chronic myeloid leukemia (CML),TRUE,,
barasertib,Phase 2/Phase 3,Aurora kinase inhibitor,AURKA|AURKB,,,TRUE,,
brigatinib,Launched,ALK tyrosine kinase receptor inhibitor|EGFR inhibitor,ALK|EGFR,oncology,non-small cell lung cancer (NSCLC),TRUE,,
camptothecin,Phase 3,topoisomerase inhibitor,TOP1,,,TRUE,,
poziotinib,Phase 2,EGFR inhibitor,EGFR|ERBB2|ERBB4,,,TRUE,,
U-0126,Preclinical,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,,,TRUE,,